Appendix — Bluestein v. Skinner
Supreme Court brief1991
Ask Donna
What actually matters in this document.
Text
IN THE
Supreme Court of the Buited States
OCTOBER TERM, 1990
MICHAEL §. BLUESTEIN, et al.,
Petitioners,
Vv.
SAMUEL K. SKINNER,
Secretary of Transportation, et al.,
Respondents.
Petition for a Writ of Certiorari to the
United States Court of Appeals
for the Ninth Circuit
APPENDIX TO
PETITION FOR. A WRIT OF CERTIORARI
WALTER KAMIAT
LAURENCE GOLD
(Counsel of Record)
815 16th Street, N.W.
Washington, D.C. 20006
(202) 637-5390
[Attorneys for Individual Petitioners Listed on Inside Cover]
WILSON - EPES PRINTING Co., INC. - 789-0096 - WASHINGTON, D.C. 20001
@ ES» co
1 tite
GARY GREEN
JERRY ANKER
1625 Massachusetts Ave., N.W.
Washington, D.C. 20036
Counsel for Air Line Pilots
Association
WILLIAM JOLLEY
204 West Linwood Boulevard
Kansas City, MO 64111
Counsel for Sheri Albert,
Charles McCune and
Independent Federation of
Flight Attendants
DEBORAH GREENFIELD
EDWARD J. GILMARTIN
1625 Massachusetts Ave., N.W.
Washington, D.C. 20036
Counsel for Association of
Flight Attendants
MICHAEL GOTTESMAN
GEORGE COHEN
Mapy GILSON
1000 Connecticut Ave., N.W.
Washington, D.C. 20036
Counsel for Association of
Professional Flight
Attendants and Independent
Union of Flight Attendants
STEPHEN P. BERZON
FRED H. ALTSHULER
MICHAEL RUBIN
177 Post Street, Suite 300
San Francisco, CA 94108
Counsel for Michael S. Bluestein
and Dean N. Chantiles
ALLISON BECK
OWEN HERRNSTADT
1300 Connecticut Ave., N.W.
Washington, D.C. 20036
Counsel for International
Association of Machinists and
Aerospace Workers
JAMES T. GRADY
GaArY S. WITLIN
25 Louisiana Avenue, N.W.
Washington, D.C. 20001
Counsel for International
Brotherhood of Teamsters,
Chauffeurs, Warehousemen
and Helpers of America
LEE SEHAM
485 Madison Avenue
New York, NY 10022
Counsel for Richard S. Linn
Scott D. RAPHAEL
1900 Avenue of the Stars
Suite 2300
Los Angeles, CA 90067
Counsel for Orange County
Airport Association
ARTHUR M. LUBY
1300 L Street, N.W.
Washington, D.C. 20001
Counsel for Transport
Workers Union of America
LARRY MANN
400 First Street, N.W.
Washington, D.C. 20001
Counsel for Transportation-
Communications International
Union
TABLE OF CONTENTS
APPENDIX A Page
Opinion of the United States Court of Appeals for
the Ninth Circuit in Michael S. Bluestein, et al. v.
Samuel K. Skinner, Secretary of Transportation,
et al., 908 F.2d 451 (July 10, 1990) 00000. la
APPENDIX B
Federal Aviation Administration, Anti-Drug Pro-
gram for Personnel Engaged in Specified Aviation
Activities; Final Rule, 58 Fed. Reg. 47024 (No-
I epee ns 16a
la
APPENDIX A
UNITED STATES COURT OF APPEALS
NINTH CIRCUIT
Nos. 88-7503, 88-7508, 89-70024,
89-70111, 89-70138 and 88-70139
MICHAEL S. BLUESTEIN; DEAN N. CHANTILES;
ORANGE COUNTY AIRPORT ASSOCIATION,
Petitioners,
v.
SAMUEL K. SKINNER, Secretary of Transportation,
DEPARTMENT OF TRANSPORTATION,
FEDERAL AVIATION ADMINISTRATION,
Respondents.
RICHARD §. LINN,
Petitioner,
v.
SAMUEL K. SKINNER, Secretary of Transportation,
DEPARTMENT OF TRANSPORTATION,
FEDERAL AVIATION ADMINISTRATION,
Respondents.
SHERI ALBERT; CHARLES MCCUNE,
Petitioners,
v.
SAMUEL K, SKINNER, Secretary of Transportation,
DEPARTMENT OF TRANSPORTATION,
FEDERAL AVIATION ADMINISTRATION,
Respondents.
2a
ASSOCIATION OF PROFESSIONAL FLIGHT ATTENDANTS,
Petitioner,
Vv.
SAMUEL K. SKINNER, Secretary of Transportation,
DEPARTMENT OF TRANSPORTATION,
FEDERAL AVIATION ADMINISTRATION,
Respondents.
INDEPENDENT UNION OF FLIGHT ATTENDANTS,
Petitioner,
V.
FEDERAL AVIATION ADMINISTRATION,
Respondent.
AIRLINE PILOTS ASSOCIATION, INTERNATIONAL,
Petitioner,
V.
FEDERAL AVIATION ADMINISTRATION,
Respondent.
Petition for Review of an Order of the
Federal Aviation Administration
Argued and Submitted Sept. 15, 1989
Decided July 10, 1990
D0 ee il aT Oe
8a
Walter Kamiat and Laurence Gold, Washington, D.C.,
for the Air Line Pilots Ass’n, Ass’n of Flight Attendants,
Intern. Ass’n of Machinists and Aerospace Workers,
Intern. Brotherhood of Teamsters, Chauffeurs, Warehouse-
men and Helpers of America, Transp.-Communications
Intern. Union.
Gary Green and Jerry Anker, Washington, D.C., for
the Air Line Pilots Ass’n.
Stephen P. Berzon, Fred H. Altshuler, and Michael
Rubin, Altshuler & Berzon, San Francisco, Cal., Seott D.
Raphael, Newport Beach, Cal., for Michael S. Bluestein,
Dean N. Chantiles, and Orange County Airport Ass’n.
Deborah Greenfield, Matthew Finucane, and Edward
Gilmartin, Washington, D.C., for the Ass’n of Flight
Attendants.
Allison Beck, Washington, D.C., for the Intern. Ass’n
of Machinists and Aerospace Workers.
James T. Grady and Wilma B. Liebman, Washington,
D.C., for the Intern. Brotherhood of Teamsters, Chauf-
feurs, Warehousemen and Helpers of America.
David Rosen and Arthur M. Luby, Washington, D.C.,
for the Transport Workers of America.
Larry Mann, Washington, D.C., for the Transp.-
Communications Intern. Union.
Lee Seham, Seham, Klein & Zelman, New York City,
Law Offices of Thornton C. Bunch, Jr., San Francisco,
Cal., for Richard S. Linn.
Stewart Weinberg, Van Bourg, Weinberg, Roger &
Rosenfeld, San Francisco, Cal., David J. Aronofsky, Arent
Fox, Kintner, Plotkin & Kahn, Washington, D.C., William
Jolley, Jolley, Walsh, Hager & Gordon, Kansas City, Mo.,
for Sheri Albert, Charles McCune, Independent Federa-
tion of Flight Attendants.
4a
Michael Gottesman, George Cohen, and Mady Gilson,
Bredhoff & Kaiser, Washington, D.C., for the Ass’n of
Professional Flight Attendants and Independent Union
of Flight Attendants.
Diane Liff, Gen. Counsel’s Office, Dept. of Transp.,
Robert V. Zener and Leonard Schaitman, Dept. of Justice,
Civ. Div., Washington, D.C., Kenneth W. Starr, Sol. Gen.,
Washington, D.C., for respondents.
Before CHAMBERS, CANBY and NORRIS, Circuit
Judges.
WILLIAM A. NORRIS, Circuit Judge:
This is a petition for review of Federal Aviation Ad-
ministration (FAA) regulations requiring random drug
testing of flight crew members, maintenance personnel,
air traffic controllers, and several other categories of
employees in the private commercial aviation industry.
Petitioners argue that the regulations violate the Fourth
Amendment and are arbitrary and capricious in violation
of §10(e) of the Administrative Procedure Act, 5 U.S.C.
§ 706(2) (A). We reject both of petitioners’ arguments
and uphold the regulations.
I. BACKGROUND
A. The Regulations
The FAA initially proposed random drug testing in an
advance notice of proposed rule making. 51 Fed.Reg.
44432 (Dec. 9, 1986). After receiving over 650 written
comments, the FAA issued a notice of proposed rule-
making. 53 Fed.Reg. 8368 -(March 14, 1988). Over 260
written comments were filed in response to this notice,
and the FAA also held a series of public hearings. The
final rule was issued on November 21, 1988. 53 Fed.Reg.
47024.
The FAA concluded that while drug use is not “wide-
spread” among commercial aviation personnel and there
++ intial
5a
is no “overwhelming” drug problem in the industry,
nevertheless the record “does show concrete evidence of
drug use in the commercial aviation sector.” 53 Fed.Reg.
47029, 47930. Accordingly, the FAA decided that “[i]n
order to ensure that aviation safety is not compromised
by a failure to detect drug users in the aviation industry,
the FAA believes that it is appropriate and necessary to
establish a comprehensive anti-drug program at this
time.” 53 Fed.Reg. 47025.
The regulations adopted by the FAA require employee
drug testing to be performed by every Part 121 and 135
certificate holder (generally, commercial air carriers,
both scheduled and unscheduled, carrying passengers or
cargo’), as well as each air traffic control facility.2 53
Fed.Reg. 47057-58 (App. I—definition of “employer’’).
The following employees must be tested: (a) flight crew
members; (b) flight attendants; (c) flight instructors or
ground instructors; (d) flight testing personnel; (e) air-
craft dispatchers; (f) maintenance personnel; (g) avia-
tion security or screening personnel; and (h) air traffic
controllers. 53 Fed.Reg. 47058 (App. I §III). Tests
must be performed for marijuana, cocaine, opiates, phen-
cyclidine (PCP) and amphetamines. Jd., § IV.
The regulations require testing of these employees on
a random basis. Jd., § V.C. To eliminate any supervisory
discretion in selecting the employees to be tested and to
avoid “potential bias toward and selective harassment
of an employee,” 53 Fed.Reg. at 8375, selection of em-
ployees to be tested must be made “using a random num-
ber table or a computer-based number generator that is
matched with an employee’s social security number, pay-
1 See 14 C.F.R. §§ 121.1, 135.1.
2 Air traffic control facilities operated by, or under contract with,
the FAA or te military are excepted. 53 Fed.Reg. 47057 App. I.
For the mos? pert, controllers at these facilities are covered by other
i drug testing programs.
| aati
6a
roll identification number, or any other alternative
method approved by the FAA.” 53 Fed.Reg. 47058,
§ V.C. After the first year of testing, employers must
conduct random tests at an annualized rate of not less
than 50 percent of the employees performing the func-
tions listed. Id., § V.C.(c) (2).°
The procedures under which the testing is to be done
are described in Procedures for Transportation Work-
place Drug Testing Program, 53 Fed.Reg. 47002 (Nov.
21, 1988) ; see also 53 Fed.Reg. 47056-61, and closely fol-
low the HHS drug-testing procedures for government
employees set forth at 53 Fed.Reg. 11,970 (April 11,
1988). Upon arriving at the “collection site,” the em-
ployee must present photographic identification or be
identified by a representative of the employer, and must
remove any outer garments, such as a coat or jacket.
The employee may choose to provide the required urine
specimen in a stall or otherwise partitioned area. The
toilet water is to be tinted with a blue dye to prevent
use of that water to adulterate the specimen, and a
monitor of the same gender as the employee must re-
main in the area, but gutside the stall. After receiv-
ing the specimen, the monitor must inspect it to ensure
that it is of proper volume, temperature, and color. The
monitor must then arrange, following specified chain-of- :
custody procedures, to ship the specimen to an HHS-
certified drug testing laboratory.
3 The regulations also require pre-employment testing, periodic
testing at the employee’s first medical examination for those em-
ployees required to take a Part 67 medical examination, post-accident
'testing, testing based on reasonable cause, and testing after return
to duty following a positive test or a refusal to test (return to
duty is authorized if the employee has completed drug rehabilitation,
and the medical review officer approves his return to work). 53
Fed.Reg. 47043-44, 47058, App. I § V. Petitioners do not challenge
these tests.
7a
The laboratory to which the specimen is sent must
perform an immunoassay test. If the specimen tests
positive, the test must be confirmed using gas chroma-
tography/mass spectrometry techniques. If the initial
positive test is confirmed, the employer’s Medical Re-
view Officer (who must be a qualified physician) de-
termines whether there is an “alternative medical ex-
planation” and in that connection must provide the em-
ployee with an opportunity to discuss the result and
submit any medical records regarding legally prescribed
medication. The employee may also demand a retest of
the original specimen at the original laboratory or an-
other HHS-certified laboratory.* In addition, there is an
absolute prohibition against the release of drug test re-
sults to third parties without the specific, written con-
sent of the employee.
Employees who test positive for prohibited drugs and
are unable to offer a satisfactory alternative explanation
must be removed from their positions, and may not re-
turn to duty except upon the recommendation of a Medi-
cal Review Officer or the Federal Air Surgeon.
B. This Litigation
Petitioners in this case include employees engaged in
various occupations within the commercial aviation in-
dustry who are subject to the FAA drug-testing rules,
the principal labor organizations in the industry, and an
organization of aviation employees and employers. Fol-
lowing the FAA’s issuance of the rules, timely petitions
for review were filed in this Circuit, the Fifth Circuit,
and the D.C. Circuit. Those petitions were then consoli-
dated in this proceeding. We have jurisdiction under 49
U.S.C.App. § 1486.
* The employee’s right to demand a retest is not part of the HHS
Guidelines for government agencies; it was added by DOT. 53
Fed.Reg. 47059, § VI.C.
8a
II. ANALYSIS
A. The Fourth Amendment Challenge
Petitioners’ primary contention is that the drug tests
required by the FAA are unreasonable searches in vio-
lation of the Fourth Amendment. Our disposition of this
issue is guided by the Supreme Court’s decisions in Na-
tional Treasury Employees Union v. Von Raab, ——
US. , 109 S.Ct. 1384, 103 L.Ed.2d 685 (1989), and
Skinner v. Railway Labor Executives Ass’n, —— US.
——, 109 S.Ct. 1402, 103 L.Ed.2d 639 (1989). In Von
Raab, the Court upheld a United States Customs Service
requirement that employees seeking transfers or promo-
tions to certain positions undergo urinalysis. In Skinner,
the Court upheld a Federal Railroad Administration pro-
gram requiring railroads to administer blood and urine
tests to train workers involved in major railroad acc:
dents, and permitting railroads to administer breath and
urine tests to employees who violate certain safety rules.
Von Raab and Skinner settle some of the threshold
questions in this case. First, drug testing performed by
private employers under compulsion of government regu-
lations constitutes governmental action subject to con-
stitutional restrictions. See Skinner, 109 S.Ct. at 1411-
12. Second, because “it is clear that the collection and
testing of urine intrudes upon expectations of privacy
that society has long recognized as reasonable,” urin-
alysis “must be deemed [a] search [] under the Fourth
Amendment.” Skinner, 109 S.Ct. at 1413; accord Von
Raab, 109 S.Ct. at 1390. Third, the usual Fourth
Amendment requirements of a warrant and probable
cause do not necessarily apply in the drug testing con-
text. Rather, when a search “serves special governmental
needs, beyond the normal need for law enforcement, it is
necessary to balance the individual’s privacy expectations
against the Government’s interests to determine whether
it is impractical to require a warrant or some level of
9a
individualized suspicion in the particular context.” Von
Raab, 109 §.Ct. at 1390.
In the present case it is clear that the FAA drug
testing requirements serve “special needs, beyond the
normal need for law enforcement” within the meaning
of Von Raab. As in Von Raab, the FAA rules specify
that “[t]est results may not be used in a criminal pros-
ecution of the employee without the employee’s consent.”
Id. Moreover, just as the Customs Service testing pro-
gram in Von Raab was designed “to deter drug use
among those eligible for promotion to sensitive positions
... and to prevent the promotion of drug users to those
positions,” id., so is the FAA’s program designed to de-
ter drug use among employees in safety-sensitive posi-
tions and to prevent the performance of safety-sensitive
functions by employees under the influence of narcotics.
We must therefore determine the constitutionality of the
FAA program by balancing the government’s interests
against the employees’ privacy interests.
In striking this balance, we take our primary guid-
ance from Von Raab, because we think that the random
testing at issue in this case is more closely analogous to
the facts of Von Raab than to those of Skinner. In Von
Raab, as in this case, the testing program did not re-
quire any level of individualized suspicion or the oc-
currence of any suspicion-triggering event; in Skinner,
on the other hand, testing was limited to those employees
involved in a train accident or safety rule violation. Ac-
cordingly, we proceed to consider whether this case can
be distinguished from Von Raab in a way that would
tip the balance against the constitutionality of the FAA’s
drug testing program.
In Von Raab, the Customs Service initiated a program
of testing employees for drugs as a condition of em-
ployment in positions that met any one of three criteria:
(1) direct involvement in drug interdiction or enforce-
10a
ment of related laws; (2) a requirement and the in-
cumbent carry a firearm; or (3) a requirement that the
incumbent handle “classified” material. See id. at 1388.
The drug tests followed procedures quite similar to the
FAA procedures at issue in this case. See id. at 1388-
89, 1394 n. 2. A union of federal employees challenged
the program as violative of the Fourth Amendment. The
Supreme Court upheld the testing program as applied to
the first two categories of employees listed above, and
remanded as to the third category (employees handling
classified information).
After concluding that the testing program invaded
reasonable expectations of privacy and that the tests were
motivated by special needs other than law enforcement,
the Court balanced the private and governmental inter-
ests at stake, and decided that the balance justified the
testing program. The Court reasoned that
[t]he Goverment’s compelling interests in prevent-
ing the promotion of drug users to positions where
they might endanger the integrity of the Nation’s
borders or the life of the citizenry outweigh the pri-
vacy interests of those who seek promotion to these
positions, who enjoy a diminished expectation of pri-
vacy by virtue of the special, and obvious, physical
and ethical demands of those positions.
Id. at 1897-98.
In reaching this conclusion, the Court rejected the pe-
titioners’ contention that there was insufficient evidence
of a drug problem in the Customs Service to justify sus-
picionless testing. The Court noted that drug abuse is
a pervasive social problem, and stressed that the testing
5 The Court found the record insufficiently clear to assess the
extent of the government’s interest in testing employees who hand!e
classified material, and therefore remanded for the court of appeals
“to clarify the scope of this category of employees subject to test-
ing.” Id. at 1397.
lla
program was aimed as much at deterrence as at detec-
tion. “In light of the extraordinary safety and national
security hazards that would attend the promotion of
drug users to positions that require the carrying of
firearms or the interdiction of controlled substances,” the
Court wrote, “the Service’s policy of deterring drug
users from seeking such promotions cannot be deemed
unreasonable.” Jd. at 1395.
The government interest in preventing drug use by
persons holding safety-sensitive positions in the aviation
industry is at least as compelling as the interest in pre-
venting drug use by Customs officers. Indeed, petitioners
concede that “the government has a strong interest in
assuring aviation safety and that the drug-related job-
impairment of any safety-sensitive aviation employee is
a basis for the most serious concern.” Reply Brief of
Petitioners at 15-16. Nonetheless, petitioners argue that
the FAA has failed to demonstrate a sufficiently high
level of drug use in the industry to justify its testing
program.
In our view, the evidence relied upon by the FAA is
stronger than the evidence relied upon by the Customs
Service in Von Raab. In Von Raab, the Service’s testing
scheme was not implemented in response to any perceived
drug problem among Service employees, and there was
evidence that only 5 employees of 3,600 tested positive
for drugs. Id. at 1394. As discussed earlier, the Su-
preme Court rejected the argument that this evidence
was insufficient to establish a substantial governmental
need, because of the deterrent purposes of the program
and the potential for serious harm. Id. at 1395.
In the present case, the FAA administrative record
included evidence that a number of pilots and other air-
line crew members had received treatment for cocaine
overdoses or addiction; that tests by companies in the in-
dustry had turned up instances of drug abuse by pilots
|
12a
and mechanics; and that drugs were present in the bod-
ies of pilots in two airplane crashes. Moreover, the
harm that can be caused by an airplane crash is surely
no less than the harm that might be caused by drug
impairment in the course of Customs Service employ-
ment. When viewed in this light, the need for the FAA’s
testing program equals, if not exceeds, that for the Cus-
toms Service program approved in Von Raab.
Petitioners also argue that the FAA testing program
intrudes more deeply on privacy interests than the pro-
gram approved in Von Raab.’ They point to the fact
that the FAA provides for unannounced (i.e., immediate)
testing, while the Customs Service program requires at
least five days’ notice; and that the FAA program is
random, while the Customs Service program is only ac-
tivated by certain events (ie. applying for certain
positions).
Although these factors add some weight to the “in-
vasion of privacy” side of the Fourth Amendment bal-
ance, they are insufficient to tip the scales against the
FAA drug testing program at issue here. The reason-
ing of the D.C. Circuit in Harmon v. Thornburgh, 878
F.2d 484 (D.C.Cir.1989), is instructive. In Harmon,
the court upheld (as to some employees) a Justice De-
partment testing plan that provided for random testing
and notice “on the same day, preferably within two
6 Although the FAA has made a showing of drug use by airline
employees, we note that nothing in Von Raab requires such a show-
ing. See Harmon v. Thornburgh, 878 F.2d 484, 487 (D.C.Cir.
1989) (“Nor is it necessary [under Von Raab] that a documented
drug problem exist within the particular workplace at issue.’’).
7 The petitioners have not urged that their expectation of privacy
is any less “diminished” than that of the Customs employees in Von
Raab. We therefore assume for the purposes of our decision that
this case is not distinguishable from Von Raab in that respect.
13a
hours, of the scheduled testing.” 878 F.2d at 486 (in-
terior quotation omitted). The court noted:
Certainly the random nature of the OBD testing
plan is a relevant consideration; and, in a particu-
lar close case, it is possible that this factor would
tip the scales. We do not believe, however, that this
aspect of the program requires us to undertake a
fundamentally different analysis from that pursued
by the Supreme Court in Von Raab.
Id. at 489. This is particularly true in light of the
FAA’s reasonable conclusion that random testing with-
out advance notice will prove to be a greater deterrent
than testing with advance notice.®
Finally, petitioners argue that the FAA plan grants
employers too much discretion. This argument is un-
persuasive. First, the strict randomness requirements
ensure that no employer will have discretion in deciding
which employees should be searched. Second, employers’
discretion as to how to structure their testing programs
will be limited by collective bargaining and the require-
ment that the FAA approve the plans of individual em-
ployers.®
In sum, we conclude that the Fourth Amendment is-
sue in this case cannot be meaningfully distinguished
from the Fourth Amendment issue addressed by the Su-
preme Court in Von Raab. We therefore reject petition-
ers’ constitutional challenge to the FAA drug testing
program.
8 For other decisions upholding random drug testing in the wake
of Von Raab, see American Fed. of Gov’t Employees v. Skinner, 885
F.2d 884 (D.C. Cir. 1989); National Fed. of Federal Employees
v. Cheney, 884 F.2d 603 (D.C. Cir. 1989); Thomson v. Marsh, 884
F.2d 113 (4th Cir. 1989).
® The FAA has stated that it will review the individual employer
programs to ensure that discretion is in fact sufficiently limited
under each plan. See 53 Fed. Reg. 47028.
l4a
B. The APA Challenge
Petitioners argue that the FAA failed to offer a satis-
factory explanation for its decision, and that the de-
cision was therefore arbitrary and capricious in viola-
tion of the Administrative Procedure Act, 5 U.S.C.
§ 706(2) (A). See Motor Vehicle Mfrs. Ass’n v. State
Farm Mutual Ins. Co., 463 U.S. 29, 43, 103 S.Ct. 2856,
2866, 77 L.Ed.2d 448 (1983) (agency must articulate
a satisfactory explanation for its action). In particular,
petitioners question the FAA’s decision to reject the rec-
ommendation of the National Transportation Safety
Board that the FAA rely on non-random forms of drug
testing.
This argument is without merit. The FAA, contrary
to petitioners’ contention, explained specifically why it
chose to require random testing, reasoning that there
was more evidence supporting the efficacy of random
testing programs than of non-random programs. See 53
Fed.Reg. 47034, 47035, 47048. Its decision that safety
concerns outweighed privacy concerns in this context was
a reasonable, if controversial, decision, and cannot be
overturned as arbitrary and capricious.
Petitioners also argue that the FAA’s decision to in-
clude flight attendants within the testing requirements
is inconsistent with prior FAA decisions denying peti-
tions of flight attendants to establish safety rules limit-
ing their on-duty time. The duty time decisions, how-
ever, do not stand for the proposition that impairment
of flight attendants’ performance is never a public safety
consideration. Rather, the FAA concluded that, on the
evidence before it, there was no correlation between flight
attendant duty time and risk to passengers. We see no
conflict between the duty time decisions and the inclu-
sions of flight attendants in the drug testing program.”
10 Although petitioners do not directly contend in this proceeding
that flight attendant positions are not safety-sensitive, it is none-
ee ee oe eet
15a
Accordingly, we hold that the FAA acted within its au-
thority in requiring random drug testing of flight at-
tendants.
III. CONCLUSION
For the foregoing reasons, we affirm the decision of
the Federal Aviation Administration.
theless worth noting that the administrative record adequately sup-
ports the FAA determination that such positions are, in fact,
safety-sensitive. Flight attendants must perform important safety
functions in the event of emergencies, and are also routinely re-
sponsible for ensuring that luggage is safely stored and the air-
plane doors properly closed and locked prior to departure.
16a
APPENDIX B
DEPARTMENT OF TRANSPORTATION
Federal Aviation Administration
14 CFR Parts 61, 63, 65, 121, and 135
[Docket No. 25148; Amdt. Nos. 61-81, 63-25,
65-32, 121-201 and 135-28]
RIN 2120-AC33
Anti-Drug Program for Personnel Engaged in
Specified Aviation Activities
AGENCY: Federal Aviation Administration (FAA),
DOT.
ACTION: Final rule.
SUMMARY: This final rule sets forth regulations to re-
quire domestic and supplemental air carriers, commercial
operators of large aircraft, air taxi and commuter oper-
ators, certain commercial operators, certain contractors
to these operators, and air traffic control facilities not op-
erated by the FAA or the U.S. military to have an anti-
drug program for employees who perform sensitive safety-
or security-related functions. A special provision has been
added to the rule that provides that the final rule does
not apply to any person where compliance with the final
rule would violate the domestic law or policy of another
country. Testing under the rule will be conducted by an
employer prior to employment, periodically, randomly,
after an accident, based on reasonable cause, and after
an employee returns to duty to perform a sensitive safety-
or security-related function for an employer. The final
rule also will require that an employer provide EAP edu-
cation and training services to employees and supervisors.
17a
The rule is necessary to prohibit an employee from, per-
forming a sensitive safety- or security-related function
for an employer while that employee has a prohibited drug
in his or her system or if that employee has used drugs
as evidenced by a drug test showing the presence of drugs
or drug metabolites. The rule is intended to ensure a
drug-free aviation workforce and to eliminate drug use
and abuse in commercial aviation.
EFFECTIVE DATE: This final rule is effective on De-
cember 21, 1988.
FOR FURTHER INFORMATION CONTACT: Dr.
Robert S. Bartanowicz, Acting Deputy Director, Office of
Rulemaking (ARM-1), Federal Aviation Administration,
800 Independence Avenue SW., Washington, DC 20591;
telephone (202) 267-9679.
SUPPLEMENTARY INFORMATION:
Availability of Final Rule
Any person may obtain a copy of this final rule by
submitting a request to the Federal Aviation Administra-
tion, Office of Public Affairs, Attn: Public Inquiry Center
(APA-230), 800 Independence Avenue SW., Washington,
DC 20591, or by calling (202) 267-3484. Requests must
include the amendment number identified in this final
rule. Persons interested in being placed on a mailing
list for future rulemaking actions should request a copy
of Advisory Circular 11-2A, Notice of Proposed Rulemak-
ing Distribution System, which describes the application
procedure.
Background
On December 4, 1986, the Federal Aviation Adminis-
tration (FAA) issued an advance notice of proposed rule-
making (ANPRM) (51 FR 44432; December 9, 1986)
entitled “Control of Drug and Alcohol Use for Personnel
Engaged in Commercial and General Aviation Activities.”
18a
The ANPRM invited comment from the public on drug
and alcohol abuse by personnel in the aviation industry
and the options available to the FAA for regulatory or
other action in the interest of aviation safety. The FAA
received over 650 written comments in response to the
issues raised in the ANPRM.
On March 3, 1988, the FAA issued a notice of proposed
rulemaking (NPRM) (53 FR 8368; March 14, 1988) en-
titled ‘‘Anti-Drug Program for Personnel Engaged in Spe-
cified Aviation Activities.” The NPRM set forth an anal-
ysis of the comments received on the ANPRM and pro-
posed regulations for public comment. The FAA received
over 260 written comments on the proposals contained in
the NPRM.
The FAA also held a series of public hearings on the
regulations proposed in the NPRM. These hearings were
held on June 2, 1988, in Washington, DC; June 7, 1988,
in Denver, Colorado; and June 9, 1988, in San Francisco,
California. Each of the hearings was recorded by a court
reporter. The transcript of each hearing and any state-
ments or other material, submitted to the hearing panel
during the hearings, have been placed in the public docket.
This material also has been reviewed in the development
of the final rule.
Current Rules. The FAA’s comprehensive anti-drug pro-
gram is one action in a long history of actions to combat the
use of drugs and alcohol in the aviation industry. The focus
of the majority of these actions has been on commercial avi-
ation personnel, particularly the cockpit and cabin crew.
For example, pilots, flight attendants, flight engineers, and
flight navigators may not act as a crewmember of a civil
aircraft within eight hours after drinking an alcoholic
beverage; while under the influence of alcohol; with 0.04
percent, or more, alcohol in their blood; or while using
any drug that affects their faculties in any way contrary
eta to hl areal
OE Nn ns AL ects Heee so
tend
hela sr Nabe 0 ae at os
a RA tt CeO ie Nad Dt Bhs ares Stet SIE ERE iin CA wept
19a
to safety. Also, crewmembers may be tested in the con-
text of receiving medical care immediately after an acci-
dent. When there is a reasonable basis to suspect that
one of these individuals has violated any of the above
restrictions, these crewmembers must furnish, to the FAA,
the results of any test taken within four hours of acting,
or attempting to act, as a crewmember that indicates the
presence of alcohol or any such drug in the person’s sys-
tem. Moreover, pilots, flight attendants, flight engineers,
and flight navigators are required to submit to a test to
indicate the percentage of alcohol in the blood when re-
quested by a law enforcement officer who suspects that a
crewmember may have violated a State or local law gov-
erning the operation of an aircraft while under the in-
fluence, or impaired by, drugs or alcohol.
The FAA may deny an application for a certificate or
rating for up to one year, or may suspend or revoke an
existing certificate or rating, in the case of any pilot,
flight engineer, or flight navigator who has been convicted
of violaiing a Federal or State law relating to drug traf-
ficking or possession; who has violated the proscriptions
described above; who has refused to furnish the results of
any test that would indicate the presence of alcohol or
drugs taken within four hours of acting, or attempting to
act, as a crewmember; or who has refused to submit to
an alcohol test requested by a law enforcement officer in-
vestigating violations of State or local laws. The FAA
also may deny an application for a certificate or rating
for up to one year, or may suspend or revoke an existing
certificate or rating, in the case of any air traffic control
tower operator, aircraft dispatcher, mechanic, repairman,
or parachute rigger who has been convicted of a violation
of a Federal or State law relating to drug trafficking or
possession.
The Aviation Drug-Trafficking Control Act of 1984,
which added language to sections 602 and 609 of the Fed-
eral Aviation Act of 1958, mandates that the FAA take
20a
certain actions regarding airmen involved in drug traffick-
ing activities. The Administrator is required to revoke
the airman certificate of any airman who has been con-
victed of violating any Federal or State law relating to a
controlled substance, other than simple possession, if an
aircraft was used in, or was used to facilitate, the com-
mission of the offense and the person served as an airman,
or was onboard the aircraft, in connection with the com-
mission of the offense. The Administrator has no discre-
tion to review the conviction for the substantive offense.
Under the 1984 legislation, the Administrator was pro-
hibited from reissuing a certificate to that airman for
up to five years but could reissue a certificate after an
absolute minimum of one year, in certain extremely lim-
ited circumstances, if revocation was excessive and con-
trary to the public interest. As part of the Federal Avia-
tion Administration Drug Enforcement Assistance Act of
1988, Congress amended sections 602 and 609 of the FAA
Act, among other amendments to the Act, in October 1988.
The statutory language now provides that the Adminis-
trator shall not issue an airman certificate to any person
whose certificate has been revoked for aviation drug
trafficking activities unless the airman is acquitted of
the offense, a conviction upon which revocation is based
is reversed on appeal, or the Administrator determines
that issuance of an airman certificate will facilitate law
enforcement efforts after a request from a Federal or
State law enforcement official. The final rule requiring a
comprehensive anti-drug program for employees in com-
mercial aviation is consistent with these previous actions
taken by the FAA.
The FAA’s commitment to a drug-free workforce also
applies to its own employees. The Department of Trans-
portation began random drug testing of DOT employees
in safety- and security-sensitive functions in September
1987. The Secretary’s goal is to establish and maintain
a drug-free workplace as intended by Executive Order
12564 and as directed by Presidential memorandum dated
aaa ieadeninaaeinemmmeiaieeeieel
2la
October 4, 1986. It is the opinion of the Department of
Transportation that random drug testing is the most
effective means of determining the presence of drugs or
drug metabolites that may adversely affect an employee’s
performance of safety- or security-sensitive job functions.
Pursuant to the Department’s program, an employee of
the Department will be removed from Federal service un-
der several circumstances: refusal to enter or to suc-
cessfully complete a drug rehabilitation or abatement pro-
gram; repeat usage of drugs; refusal to provide a urine
specimen for drug testing; adulteration or substitution
of a urine specimen; on-duty use of illegal drugs; or
a determination that a DOT employee has engaged in
illegal drug trafficking.
In order to ensure that aviation safety is not compro-
mised by a failure to detect drug users in the aviation
industry, the FAA believes that it is appropriate and
necessary to establish a comprehensive anti-drug program
at this time.
Existing Industry Programs. As part of their com-
ments to the ANPRM and the NPRM, many employers
note that they have implemented drug testing programs
or employee rehabilitation programs. For example, al-
though their drug testing programs were not specifically
described, Martin Aviation implemented a drug testing
program in February 1987 and Suburban Airlines has re-
quired preemployment drug testing of flight crew appli-
cants for over a year. Federal Express Corporation cur-
rently conducts preemployment testing of all applicants
and “reasonable suspicion testing” of all employees.
Tramco, Ine. is a certificated repair station employing
over 600 individuals and repairing over 100 aircraft per
year. Tramco instituted a drug testing and counseling
program “several years ago” and believes that the pro-
gram yields substantial benefits to both employees and
employers. Tramco tests all applicants for jobs and con-
ducts tests based on probable cause. Tramco’s tests based
22a
on probable cause are triggered by reports of employee
drug use, employee attendance patterns that may suggest
a drug problem, accidents, and observation by super-
visors. A Tramco employee who tests positive for drugs
is suspended for a minimum of one week and may not
return to work until a drug test shows no evidence of
drug use. Tramco estimates that, consistent with general
statistics, 20 percent of its workforce has had some in-
volvement with controlled substances. As of the time of
its comment to the NPRM, Tramco identified 10 percent
of its employees as individuals who had used drugs.
Rocky Mountain Helicopters, Inc. implemented a drug
testing program for its employees in July 1986. Rocky
Mountain Helicopters tests all pilots, mechanics man-
agers, and others who can affect aviation safety using
preemployment, random, probable cause, and postaccident
testing. Rocky Mountain Helicopters does not pay an em-
ployee’s rehabilitation costs but will consider rehiring any
employee who completes an approved rehabilitation pro-
gram. Petroleum Helicopters, Inc. began a preemploy-
ment and periodic testing program in 1982 and supports
mandatory drug testing. Petroleum Helicopters denies
employment to any applicant, and discharges any em-
ployee, who tests positive in a drug test. Petroleum Heli-
copters does not concur with the proposal to provide a
rehabilitation opportunity to employees on the basis that
an employer should not accept the risk of repeated illegal
drug use among maintenance or flight personnel. -
The FAA believes that the comprehensive anti-drug
program, promulgated by this final rule, is not a novel
concept. In light of the FAA’s long history of regulatory
action in the area of drug use in aviation and the sig-
nificant number of industry drug testing programs cur-
rently implemented by aviation employers, the FAA be-
lieves that the agency is justified in requiring the com-
mercial aviation industry to implement similar compre-
hensive anti-drug programs.
23a
Discussion of Comments
General Overview of the Major Issues
The FAA received 261 comments in response to the
NPRM. The FAA considered all timely-filed comments
submitted in response to the NPRM and the testimony
of 20 individuals who presented statements at the three
public hearings held by the FAA. During the public
hearings, the Secretary of Transportation, James H.
Burnley, requested information from several individuals
who presented statements at the hearings. The comment
period for the NPRM closed on June 13, 1988. In order
to accommodate the individuals who submitted supple-
mental information pursuant to the Secretary’s request,
the FAA also considered comments that were submitted
as late as July 1, 1988.
There were several major themes presented by the
commenters. Many commenters focus on the lack of evi-
dence of significant drug use or drug abuse in the avia-
tion industry. The commenters particularly stress this
point with respect to the cockpit crew based on age, in-
come, managerial supervision, close working relationships
with peers, periodic medical exams to determine fitness
for duty, and professionalism of the crew. Based on the
lack of evidence, these commenters conclude that estab-
lishment of a drug testing program is unwarranted and
unconstitutional. Regardless of the amount of evidence,
the majority of commenters agree with the FAA’s assess-
ment that drug use and substance abuse have no place in
the aviation environment. Some commenters note that
the FAA’s anti-drug stance is commendable, but the true
issue is the type of program that evolves from that
stance. Many commenters support the FAA’s efforts to
develop a comprehensive anti-drug program that would
achieve a drug-free commercial aviat‘on workforce and
agree that a program to achieve a drug-free aviation
environment is beneficial.
24a
There is substantial, although not universal, support
for a drug testing program using state-of-the-art urine
testing. The gas chromotography/mass_ spectrometry
(GC/MS) method, approved by the Department of Health
and Human Services (DHHS), is recognized by the com-
menters as the most accurate method of analysis for the
presence of drugs or drug metabolites in urine if rigorous
collection and analysis procedures, such as those contained
in the DHHA mandatory guidelines, are followed. (As
discussed in detail elsewhere in this preamble, the Depart-
ment of Transportation is publishing “Procedures for
Transportation Workplace Drug Testing Programs”
which are adopted in this final rule in lieu of the DHHS
guidelines. These DOT-wide procedures closely resemble
the DHHS guidelines and are used-because the DHHS
guidelines are not drafted for application by entities
other than Federal agencies.) While some concerns were
raised about the testing procedures, these concerns gen-
erally involve drug testing programs and procedures in
the early 1980s that did not embody the critical safe-
guards of a properly-administered testing program.
Certain types of testing proposed in the NPRM receive
significant support by the commenters. These types of
testing include preemployment testing and postaccident
testing. Periodic testing and testing based on reasonable
cause received substantial support from the commenters.
Some support for testing based on reasonable cause is
predicated on traditional constitutional standards that
apply to a search of the person.
There is significant and strongly-held opposition to
random testing. However, the FAA’s drug testing pro-
gram, including random testing as a critical element, is
supported by some commenters. The objections to random
testing are based on legal or constitutional issues, pri-
vacy issues, privacy issues, and the invasive nature of
random testing based on personal grounds, cost issues,
and the absence of a demonstrated need for a compre-
25a
hensive testing program assuming a low level of drug use
in the industry.
Of those commenters who address the issue, there is
agreement that the complexity, cost, and operational im-
pact burdens of the rule would be significantly greater
on small entities in the aviation industry. Finally, the
commenters express significantly different opinions in the
area of employee assistance programs (EAP). The pri-
mary differences surround the issues of the circumstances
under which an employee is offered an opportunity for
rehabilitation and the entity or individual who is respon-
sible for payment of rehabilitation costs. Several major
air carriers have already addressed this issue through
insurance coverage or by labor-management agreement.
However, even some of these organizations, although sup-
portive of EAPs, oppose a broad, Federally-mandated
EAP requirement. Labor organizations clearly support
expansive EAP opportunities and services. Small entities
oppose EAP requirements on many grounds, including
cost and possible negative coworker attitudes exhibited
toward rehabilitated employees.
The commenters differ regarding the method of achiev-
ing a drug-free aviation workforce and the manner in
which the FAA would be involved in any program. The
primary differences arise regarding the type and scope
of testing used to identify sensitive safety- or security-
related personnel who use drugs and the choices offered
to those individuals who are identified as drug users.
Labor Unions and Organizations Representing Em-
ployees. In general, unions or organizations representing
employees in aviation oppose the comprehensive manda-
tory drug testing proposed in the NPRM. Labor unions
and employee organizations favor EAP and broad re-
habilitation rights for all employees. These organizations
oppose random drug testing but, with some qualifications,
these organizations see a role for preemployment testing,
26a -
postaccident testing, testing based on reasonable cause,
and testing during and after rehabilitation to monitor an
individual’s progress.
The International Association of Machinists and Aero-
space Workers (IAM) opposes any industry-wide drug
and alcohol testing until hard evidence of an industry
drug problem that jeopardizes aviation safety is substan-
tiated and documented. The Independent Union of Flight
Attendants (IUFA) opposes all forms of mandatory drug
testing of employees. The Independent Federation of
Flight Attendants (IFFA) objects generally to drug test-
ing as unwarranted governmental intervention into labor-
management relations but would support preemployment
screening and postaccident testing if reasonable cause for
such testing can be objectively illustrated. IFFA objects
specifically to random testing in any form as unconstitu-
tional and contrary to labor law. IFFA believes that the
focus of any drug testing program should be limited to
impairment on the job and states that no currently avail-
able testing procedure can determine drug impairment on
the job. The Asscciation of Flight Attendants (AFA)
believes that drug testing of flight attendants is not
warranted. However, AFA and the Association of Pro-
fessional Flight Attendants (APFA) support preemploy-
ment testing of applicants seeking jobs in the industry if
that testing is not used to discriminate against applicants
on the basis of disabilities unrelated to drug use. AFA
also would not oppose postaccident testing of pilots or
probable cause drug testing of employees who are under
the influence of drugs if these samples were collected by
an FAA inspector. APFA opposes random testing, post-
accident testing absent individualized suspicion, and test-
ing based on reasonable cause as proposed. The Flight
Engineers’ International Association (FEIA) opposes all
testing except in the case where probable cause exists to
believe that an employee is impaired by drugs; in order
to protect employees from harassment, FEIA states that
OE en eee
27a
any determination to test an employee based on probable
cause for impairment should be reviewed by a neutral
party. The Teamsters Union could support preemploy-
ment screening; testing based on reasonable suspicion to
believe that an employee’s actual or current impairment
has, or is, affecting job performance or workplace safety;
periodic testing to maintain medical certification; and
testing after an accident or a “near miss” if there is a
reasonable basis to suspect that human error may have
been a causal factor.
The Air Line Pilots Association (ALPA), representing
41,000 pilots employed by 44 large and small airlines, is
firmly opposed to all forms of drug and alcohol abuse by
airline personnel. ALPA primarily is opposed to random
and periodic testing based on their belief that these tests
are offensive, ineffectual, unjustified, and unconstitu-
tional. ALPA believes that if there is drug use among
commercial pilots, the incidence of drug use would be less
than 0.5 percent. On this basis, ALPA asserts that wide-
scale random testing of the relatively small aviation popu-
lation will result in a significant number of false-positive
test results. ALPA does not oppose testing prior to em-
ployment, testing after an accident, testing in circum-
stances where there are reasonable grounds to suspect
drug use, and testing to monitor rehabilitation.
ALPA believes that the approach to the drug abuse
problem articulated in the NPRM is inappropriate.
ALPA instead urges the FAA to consider an approach
similar to the Human Intervention Motivation Study
(HIMS) program developed to identify and treat alco-
holism among pilots. The key elements of the HIMS
program are education, peer involvement, intervention,
confrontation, and rehabilitation. Although the HIMS
program has focused on treatment of pilots who demon-
strate a problem with alcohol, ALPA sponsored a HIMS
drug abuse training program in November 1987 which
the FAA attended.
28a
Labor and employee organizations also strongly sup-
port limitations on an employer’s ability to exclude any
employee from an opportunity for rehabilitation and limi-
tations on an employer’s ability to discharge an em-
ployee. Most organizations, including IUFA, IFFA, AFA,
and APFA, strongly support regulations that would re-
quire an employer to establish and participate in compre-
hensive, nonpunitive EAP services established by collec-
tive bargaining or negotiation and available to all em-
ployees. ALPA agrees that any regulations should clearly
recognize that unions have collective bargaining rights
under Federal labor laws; ALPA suggests that any anti-
drug regulations promulgated by the FAA should ensure
that the regulatory requirements do not interfere or over-
ride the union’s collective bargaining rights. FEIA sup-
ports EAP services, mandatory for each carrier and paid
for by the carrier, for rehabilitation of all employees re-
gardless of the circumstances that precipitated a drug
test. IAM suggests that FAA regulations should be
guidelines, applicable only to carriers who have a docu-
mented substance abuse problem affecting aviation safety,
that stress education, prevention, rehabilitation, and pro-
tection of an employee’s privacy.
Employers and Organizations Representing Employers.
Most employers support mandatory drug testing of em-
ployees and limitations on an employees opportunity for
rehabilitation. Part 121 and Part 135 certificate holders
do not express the same opinions regarding the proposals
in the NPRM. The general views held by Part 121 cer-
tificate holders are characterized by the comments sub-
mitted by the Air Transport Association of America
(ATA). ATA supports the FAA’s comprehensive drug
testing program and favors an opportunity for rehabili-
tation only for those employees who volunteer for re-
habilitation. In the area of EAP services, Part 121 cer-
tificate holders generally favor flexibility and latitude for
an employer to design a company EAP. American Air-
- he Lee ee
29a
lines, however, favors industry-wide standard EAP re
quirements.
Most Part 135 certificate holders and small aviation
businesses object to the drug testing requirements pro-
posed in the NPRM. The Regional Airline Association
(RAA), which represents many Part 135 certificate hold-
ers, opposes random testing; RAA also suggests that the
random selection rate be set at a rate less than the maxi-
mum 125 percent rate proposed in the NPRM if the FAA
mandates a random testing requirement. The Primary
objection of Part 135 certificate holders and small busi-
nesses is to the proposed requirement to offer an oppor-
tunity for rehabilitation to an employee. These organiza-
tions oppose mandated rehabilitation because of the eco-
nomic burden that would be imposed on a small operator.
The National Air Transport Association (NATA) sug-
gests, in its June 2, 1988 testimony, that Part 135 cer-
tificate holders employing 100 or fewer covered employees
should be exempted from all requirements of the proposed
anti-drug program.
Grace Flying Service, Inc., a Part 135 certificate holder
conducting single-engine air taxi services, flight instruc-
tion, and aerial application services, opposes drug testing
of employees. Grace Flying Service strenuously objects
to any drug tests, whether scheduled or random, and
would be reluctant to test its employees even if testing is
mandated by the FAA.
The National Business Aircraft Association (NBAA)
concurs with the FAA’s anti-drug program with certain
reservations. NBAA primarily is concerned about the
constitutionality of random drug testing and the FAA’s
reliance on laboratory testing results that may be un-
reliable in detecting drugs or drug metabolites proposed
to be analyzed in the NPRM.
Individual Commenters. The FAA received 170 com-
ments from individuals. The majority of these individ-
30a
uals are pilots employed by major airlines and self-
employed pilots who would be subject to the requirements
of the proposed rule. The FAA also received comments
from general aviation pilots and individuals who are not
employed in the commercial aviation industry. The vast
majority of the individual commenters oppose the drug
testing requirements of the proposed rule based on con-
stitutional objections, failure of the FAA to demonstrate
a drug problem in the aviation community, and perceived
inaccuracies of drug testing collection and analysis. A
minority of individual commenters generally support the
FAA’s anti-drug proposals and primarily support the
testing requirements. These individuals are private citi-
zens or consumers who base their support on the need to
ensure that aviation personnel are drug free, particularly
on the job. The strongest individual support is expressed
by letters from the family and friends of a passenger
who was killed in the crash of Continental Air Express
Flight 2286 near Durango, Colorado. The comments from
the family and friends of the deceased passenger urge
the FAA to do everything within its statutory authority
to prevent a similar tragedy in the future.
Specific Issues
Discussion of the constitutional! issues regarding ran-
dom and periodic drug testing. A number of commenters
have questioned the constitutionality of drug testing pro-
grams for aviation personnel. Although the state of the
case law is still evolving in rapid fashion and no defini-
tive Supreme Court resolution of many relevant and com-
plex issues has been achieved, the FAA feels confident
that testing required under this rule will pass constitu-
tional scrutiny. The FAA recognizes that there are legit-
imate and significant constitutional concerns surrounding
drug testing in general and random drug testing as a
specific component of drug testing. The FAA acknowl-
edges the current widescale litigation and apparent dis-
parate judicial opinions on drug testing programs.
ee ee ‘ mits tem" ob
ey
Seat ce Rete a ate ie see ade
3la
FAA Response. The principles of the Fourth Amend-
ment to the U.S. Constitution are paramount in scrutiniz-
ing the fundamental legality of many drug testing pro-
grams. As a threshold legal matter, the Fourth Amend-
ment applies to “searches” conducted or mandated by the
government and protects individuals against “unreason-
able searches and seizures.” Action of a private party
does not constitute State (or Federal) action unless there
exists a close nexus between the state and the action
in question. Jackson v. Metropolitan Edison, 419 US.
345 (1974); Moose Lodge No. 107 v. Irvis, 407 U.S. 162
(1972).
Assuming that the drug testing programs called for
under the final rule do implicate the government, a second
issue then arises concerning whether urine tests under
these programs are “searches” within the meaning of the
Fourth Amendment. Although most courts to address the
issue to date have ruled that toxicological testing of em-
ployees for the purpose of determining fitness for duty
is a search within the meaning of the Fourth Amendment,
the issue is not entirely settled. See Wyman v. James,
400 U.S. 309, 317-338 (1971) (government welfare case-
worker’s “home visit” as a precondition for assistance
payments is not a Fourth Amendment search). See also,
Lovvorn v. City of Chattanooga, 846 F.2d 1539, 1553-
1554 (6th Cir. 1988) (Guy, J., dissenting), panel decision
vacated and rehearing en bane ordered, (August 3,
1988) ; National Treasury Employees Union v. von Raab,
808 F.2d 1057, 1060, 1062 (5th Cir. 1987) (Higgin-
botham, J., concurring). Cf. Mack v. United States,
F.B.I., 814 F.2d 120, 125 n.2 (2nd Cir. 1987).
Also assuming, arguendo, that urine tests of aviation
personnel for illegal drugs are “searches” within the
meaning of the Fourth Amendment, it is clear that while
searches ordinarily must be conducted pursuant to a war-
rant issued on probable cause grounds, such a require-
ment is not always necessary. Almeida-Sanchez v. United
32a
States, 4138 U.S. 266, 277 (1973) (Powell, J., concur-
ring). Where, for example, “* * * the burden of obtain-
ing a warrant is likely to frustrate the governmental
purpose behind the search * * *,” [Camera v. Municipal
Court, 387 U.S. 528, 583 (1967)], the Supreme Court
has routinely held that a warrant is not required by the
Fourth Amendment. See e.g., Griffin v. Wisconsin, 107
S.Ct. 3164, 3167 (1987); New Jersey v. T.L.O., 469 U.S.
325, 340 (1985). The Supreme Court has likewise found
that the probable cause standard is inappropriate where
it would defeat the purpose that the search is designed to
achieve. See e.g., New Jersey v. T.L.0., 469 U.S. at 340-
342; O'Connor v. Ortega, 107 S.Ct. 1492, 1501-1502
(1987) (plurality opinion) (upholding the search of a
public employee’s office for work-related noninvestigatory
reasons on less than probable cause grounds); United
States v. Martinez-Fuerte, 428 U.S. 548, 560-561 (1976)
(footnotes omitted) (while “* * * some quantum of indi-
vidualized suspicion is usually a prerequisite to constitu-
tional search or seizure,] * * * the Fourth Amendment
imposes no irreducible requirement of such suspicion’’).
Rather, “[t]he fundamental command of the Fourth
Amendment is that searches and seizures be reasonable
** *” New Jersey v. T.L.0., 469 U.S. at 340. In deter-
mining the reasonableness of a search, the Supreme Court
has repeatedly stressed the importance of the facts par-
ticular to the search while acknowledging that the test
of reasonableness “* * * is not capable of precise defini-
tion or mechanical application.” Bell v. Wolfish, 441 U.S.
520, 559 (1979). In analyzing a drug testing program,
«* * * what is reasonable depends on the context within
which a search takes place.” New Jersey v. T.L.O., 469
U.S. at 337.
In scrutinizing whether particular searches comport
with the Fourth Amendment, courts have adopted a bal-
ancing test. In general, to support a claim that a search
of an individual or the individual’s property is reason-
ae ee
te al ae nn er ee
wet.
to Dee me Ladi —
~ <ebtad ed se
:
9
33a
able, the government must demonstrate that, on balance,
the public’s legitimate interest on conducting the search
outweighs the individual’s legitimate expectation of pri-
vacy. See e.g., United States v. Montoya de Hernandez,
473 U.S. 531, 587 (1985); United States v. Villamonte-
Marquez, 462 U.S. 579, 588 (1983) ; Delaware v. Prouse,
440 U.S. 648, 654 (1979). Thus, the courts must “* * *
consider the scope of the particular intrusion, the manner
in which it is conducted, the justification for initiating
it, and the place in which it is conducted.” Bell v. Wol-
fish, 441 U.S. at 559.
Viewed in this light, it is beyond dispute that the public
has an overriding interest in assuring that sensitive
safety- and security-related aviation personnel perform
their duties free of illegal drugs. The drug problem in
society in general and evidence of drug use in the avia-
tion industry in particular are documented elsewhere in
the preamble of this final rule. The impairing effects of
illegal drugs and the substantial risks to public safety
posed by aviation employees who use illegal drugs under-
lies the compelling governmental interests in promulgat-
ing this final rule.
In contrast, the drug testing requirements of the final
rule involve a minimal invasion of privacy. As the Su-
preme Court has indicated, where searches are under-
taken in situations where individualized suspicion is lack-
ing, other safeguards must be relied upon to ensure that
the discretion of the party conducting the search is prop-
erly defined and the scope of the search is limited. See
Delaware v. Prouse, 440 U.S. at 654-655 (footnote
omitted); New York v. Burger, 107 S.Ct. 2686, 2648
(1987). The drug testing requirements of the final rule
place significant constraints on an employer’s discretion
in conducting drug testing. For example, the requirement
for random drug testing calls for selection of an employee
to be tested in a scientifically-acceptable manner, such as
use of a computer-based random number generator. Re-
34a
quirements for testing based on reasonable cause cr post-
accident testing also are severely circumscribed in order
to limit an employer’s discretion in administering such
tests to employees. Also, the FAA will review the actual
employer anti-drug programs, required to be submitted
to the agency in accordance with provisions of the final
rule, to ensure that discretion is in fact limited in the
administration drug tests under these programs. Cf.
National Treasury Employees Union v. Reagan, No. 86-
4058, slip op. at 14 (E.D.La. April 29, 1988) (holding
that the constitutionality of Executive Order requiring
Federal agencies to establish drug testing programs for
Federal employees was not ripe for review since each
agency had not implemented a finalized, particular plan).
The actual testing procedures that each employer is
required to implement under this final rule also are
tailored narrowly to respect an employee’s reasonable
expectation of privacy. The DOT procedures governing
collection of urine samples, which are based on the
DHHS guidelines, are carefully designed to preserve pri-
vacy while protecting the integrity of the sample. The
final rule contains a number of important employee safe-
guards, including privacy during collection under the
majority of circumstances, stringent laboratory safe-
guards, and provisions for challenging results. Other
employee drug testing programs incorporating the collec-
tion and testing procedures of the DHHS guidelines have
been upheld against constitutional attack. The DOT pro-
cedures so closely resemble the HHS guidelines in all
pertinent respects that the Department of Transporta-
tion is confident that these procedures also will be upheld.
See American Federation of Government Employees v.
Dole, 670 F.Supp. 45 (D.D.C. 1987), appeai docketed,
No. 87-5417 (D.C.Cir. Dec. 11, 1987) (upholding the
constitutionality of the Department of Transportation
program for random drug testing of safety- and security-
sensitive agency employees) ; National Association of Air
Traffic Specialists v. Dole, 2 Ind.Emp.Rts. Cases (BNA)
eh eS A
<< mI
ile Petite cial Se EE AN ORI Chee Brvenecttlnn bial Ws
35a
68 (D.Alaska 1987) (denying a motion for a preliminary
injunction against the FAA use of urinalysis drug test-
drug testing as part of an annual physical examination
of the agency’s air traffic specialists) .
Equally significant is the fact that urine drug testing
of sensitive safety- and security-related employees is to
be conducted in the “context” of the employment rela-
tionship. As the Supreme Court has pointed out, “[t]he
operational realities of the workplace * * * may make
some employees’ expectation of privacy unreasonable.”
O’Connor v. Ortega, 107 S.Ct. at 1498. This is particu-
larly important in circumstances where the employee
works in an industry in which his or her activities are
subject to extensive regulation. Thus, persons who work
in such “closely regulated” industries have a “reduced
expectation of privacy” [New York v. Burger, 107 S.Ct.
at 2646] and, “in effect consent[] to the restrictions
placed upon them” [Almeida-Sanchez v. United States,
413 U.S. at 271]. For these very reasons, two Federal
courts of appeals have upheld urinalysis testing, in the
absence of particularized suspicion, in industries where
pervasive regulation of privacy. See Rushton v. Nebraska
Public Power Dist., 844 F.2d 562, 566 (8th Cir. 1988)
(nuclear plant operators); Shoemaker v. Handel, 795
F.2d 1136, 1142 (8rd Cir.), cert. denied, 479 U.S. 986
(1986) (jockeys); Policemen’s Benevolent Ass’n., Local
818 v. Township of Washington, 850 F.2d 133 (8rd Cir.
1988) (police officers).
It is beyond dispute that aviation has always been
subject to pervasive regulation by the government and
by employers themselves. As one Federal district court
has noted:
[t]he rationale of the Third Circuit upholding
drug urinalysis for jockeys in order to protect the
integrity of horse racing is even more compelling
when the public need for air safety is considered.
If horse racing is recognized as a closely or perva- .
36a
sively regulated activity, then aviation activities and
the aviation industry are as much or possibly more
closely regulated.
Indeed, the creation of a federal agency charged
with the responsibility for ensuring safe air travel
reflects the public interest in air safety. * * * [T]he
public perception of air safety not only is critical to
the airline industry but to all who fly. * * * [C]lose
and pervasive regulation of aviation related activi-
ties is well established and * * * air safety relates to
serious risk or hazards which require close and con-
stant attention. National Association of Air Traffic
Control Specialists v. Dole, 2 Ind. Emp. Rts. Cases
(BNA) at 78.
The FAA recognizes that a number of Federal and
State courts have rejected government-mandated drug
testing program of Fourth Amendment grounds. How-
ever, even courts striking drug testing programs have
recognized that drug testing is appropriate in other con-
texts. See e.g., Lovvorn v. City of Chattanooga, 846 F.2d
at 1553-1554 (Martin, J.) (“When determining then,
whether a mandatory drug search is ‘reasonable,’ we be-
lieve that, as the costs to society of an impaired em-
ployee increase, the requisite level of suspicion that a
drug problem exists decreases.”) ; Policemen’s Benevolent
Ass’n, Local 318 v. Township of Washington, 672 F.Supp.
779, 792 (D.N.J. 1987), rev’d, 850 F.2d 133 (8rd Cir.
1988) (“[T]he need to prevent a major airline disaster
presents a far more compelling rationale than those pre-
sented by the municipality in support of testing its po-
lice officers.”’) ; American Federation of Government Em-
ployees v. Meese, No. C-88-1419-SAW (N.D.Cal. June 16,
1988) (issuing a preliminary injunction against a Bu-
reau of Prison plan to test randomly all agency em-
ployees but nonetheless noting that “[t]here are cases in
which compulsory drug testing may be justified in the
interest of public safety or security.” Memorandum opin-
ion at 2).
“=, oe eS oe
SN ea eS See SS
37a
The FAA also is aware of the recent Ninth Circuit
decision holding unconstitutional regulations promulgated
by the Federal Railroad Administration—mandating
blood and urine tests of railroad employees who are in-
volved in certain train accidents and fatal incidents and
authorizing breath and urine tests after certain acci-
dents, incidents, and rule violations—because the rules_
do not require a showing of “particularized suspicion”
drug or alcohol impairment prior to testing. Railway
Labor Executives’ Association v. Burnley, 839 F.2d 575
(9th Cir.), cert. granted, 108 8.Ct. 2033 (1988). The
Ninth Circuit based its views, in part, on the proposition
that “* * * the vast bulk of [railroad] safety regulation
is directed at owners and managers of railroads, not em-
ployees.” Id. at 585. The U.S. government disagrees with
the Ninth Circuit panel’s decision, which is contrary to
rulings in other Federal appellate courts. Moreover, con-
trary to the Ninth Circuit’s views of the Federal Rail-
road Administration’s jurisdiction over railroad employ-
ees, FAA’s jurisdiction over employees in the aviation
industry is clear and should not be _— to challenge
on this basis.
The Supreme Court has granted the government’s pe-
tition for a writ of certiorari in Railroad Labor Execu-
tives’ Association v. Burnley and has ordered that this
case be argued this term “in tandem” with National
Treasury Employees Union v. von Raab, 816 F.2d 170
(5th Cir. 1987), cert. granted, 108 S.Ct. 1072 (1988) -
(upholding drug testing of applicants for critical safety
or security sensitive positions in the U.S. Customs Serv-
ice). Decisions in these cases may not be forthcoming
until the spring of 1989. However, in the absence of
Supreme Court guidance, the FAA remains convinced
that the need for drug testing by urinalysis in the avia-
tion industry to determine fitness for duty of sensitive
safety-or security-related employees and, thereby, to en-
sure public safety clearly outweighs the privacy inter-
est of individuals in this class.
38a
While not totally free from doubt, it is the opinion
of the Department of Transportation that the FAA’s
anti-drug program, and similar regimens proposed by
other administrations within the Department, will be
determined to be constitutional. The critical need for
properly-administered drug testing to ensure that em-
ployees in the transportation industry do not have drugs
or drug metabolites in their system while performing
sensitive safety- and security-related functions out-
weighs the reduced privacy interest of these employees.
Lack of Evidence of a Drug Problem in the Aviation
Industry. Nearly every commenter who opposes drug
testing in general, and random testing in particular, and
even commenters who support the comprehensive drug
testing proposals, raise the issue of lack of evidence of
a drug problem in commercial aviation. On this basis,
the commenters assert that the FAA can not justify the
comprehensive proposals contained in the NPRM. ALPA,
the Aircraft Owners and Pilots Association, (AOPA),
and the organizations representing flight attendants
maintain that the industry should police itself in the area
of drug use and abuse.
FAA Response. The FAA made no attempt to ob-
scure the lack of widespread evidence of drug use or
abuse among commercial aviation personnel. However,
after publication of the NPRM in the Federal Register
on March 14, 1988, federal investigators released prelimi-
nary data showing that the captain of Continental Air
Express Flight 2286, which crashed in Durango, Colo-
rado on January 19, 1988, may have been impaired by
drugs while operating the aircraft. A preliminary report
of the National Transportation Safety Board (NTSB)
indicates that toxicological test results show that the cap-
tain of Flight 2286 had cocaine and a cocaine metabolite
in his system at the time of the crash. Seven passengers
and the pilot and copilot died in the accident.
39a
In 1983, the NTSB issued an Aircraft Accident Re-
port (NTSB/AAR-84/11) on the crash of Central Air-
lines Flight 27 in Newark, New Jersey, on March 30,
1983. The NTSB determined that the probable cause of
the crash of the Gates Learjet nonscheduled, cargo-carry-
ing aircraft included “impairment of the flight crew’s
judgment, decisionmaking, and flying abilities by a com-
bination of physiological and psychological factors.” The
NTSB did not conclude that drug-impaired performance
was the sole cause of the crash. However, the report
does state that test results indicate that the captain had
used marijuana and the copilot had used, or been ex-
posed to, marijuana within the 24 hours preceding the
crash. Also, toxicological tests indicate that the co-
_ pilot’s urine showed evidence of contra-indicated use of
an antihistamine drug.
Additional evidence of illegal drug use by individuals
employed in the airline industry appeared in the fall of
1986, when a series of articles in the Pittsburgh Press,
based on interviews with emergency room’staffs at area
hospitals, highlighted 23 cases of airline flight crew drug
abuse. Twenty of those cases involved cocaine overdoses,
two were heroin reactions, and one dealt with valium and
alcohol. Twelve cockpit crewmembers and eleven cabin
crewmembers were among those treated by Pittsburgh
area hospitals also indicated that they had treated nu-
merous cases of drug abuse among non-flight employees,
such as mechanics. The Pittsburgh Press also, surveyed
17 drug treatment clinics across the country and found
that more than 69 pilots had been treated for cocaine ad-
diction. A subsequent FBI investigation of drug use in
the Pittsburgh area produced evidence that a number of
airline ernployees, including cockpit, cabin, and ground
crewmembers, had used cocaine, marijuana, and other il-
legal drugs, sometimes on duty or shortly before report-
ing for duty.
The NPRM also included comments by a Part 121 and
Part 135 certificate holder that implemented an unan-
“40a
nounced drug testing program applicable to its employ-
ees. This company reported that 2.5 percent of its 180
pilots and 4 percent of its 240 mechanics tested positive
for a trace, or more, of illegal drug in their system.
Data from the airline industry regarding preemployment
screening of applicants for various positions indicate that
the number of positive drug tests ranges from 4.2 per-
cent to 20 percent with results as high as 25 percent to
30 percent in some geographical locations.
Although this data does not show an overwhelming
drug problem in commercial aviation, it does show con-
crete evidence of drug use in the commercial aviation
sector. The FAA recognizes that commercial aviation
personnel operate in a professional and highly-regulated
environment. Howevér, pursuant to the FAA’s statu-
tory mandate to ensure aviation safety, the FAA also
must acknowledge that commercial aviation personnel
are not immune to, nor insulated from, drug use or
abuse that may affect safety-critical job performance.
The FAA believes that any drug use in commercial avia-
tion warrants preventive and proactive intervention by
the FAA to ensure aviation safety. The FAA believes
that this view is not inconsistent with the increasing
awareness of several aviation employers who currently
have, as disclosed in their comments, basic drug testing
and employee rehabilitation programs for their employ-
ees.
Although not a universally-expressed opinion among
the commenters, ATA “fully embrace[s] the philosophy,
expressed in the NPRM, that individuals who wish to
work in aviation activities that involve the safety of
passengers, co-workers, and others must not use illicit
drugs, even while off-duty.” Several commenters, in-
cluding RAA, note that to the extent any drug use is
occurring in the aviation industry, it is a “safety issue
and it is well within the purview of the FAA to develop
a comprehensive, nationally applicable set of regulations.”
4la
The Equal Employment Advisory Council (EEAC) be-
lieves that the workplace is an appropriate environment
to intervene in the process of individual substance abuse.
EEAC also believes that the FAA has correctly concluded
that the purpose of drug testing is not to determine that
an employee is impaired by drugs at the time of testing.
Instead, testing is used to enable an employer rationally
to determine if an employee has used drugs and to con-
clude reasonably that there is a possibility of future im-
pairment based on subsequent use.
Comments that the Proposed Rules are Politically-
Motivated. The FAA received many comments that state
that the comprehensive anti-drug program proposed by
the FAA is based solely on political perceptions and
goals. The commenters stress that DOT and the FAA
have surrendered to the public hysteria over drug use
and unfavorable press reports of drug use in the avia-
tion industry.
FAA Response. Because this issue is raised so fre-
quently by the commenters, the FAA chooses to address
these comménts although they are beyond the scope of
the rulemaking. The war against drugs is one of this
Administration’s top priorities. Also, Congress has en-
acted a substantial amount of legislation to address the
use, distribution, importation, and interdiction of drugs
in the United States and is considering enactment of ad-
ditional legislation. Moreover, a significant number of
public opinion polls indicate that the American public
is deeply concerned about the effect of drug use by in-
dividuals in critical safety occupations, including avia-
tion. The fact that the Administration, Congress, and
the public are concerned about drug use is noteworthy.
However, the FAA is issuing the comprehensive anti-
drug program in this final rule because it is consistent
with the FAA’s statutory duty to promulgate minimum
standards to ensure and promote aviation safety.
42a
DHHS Guidelines. The FAA received numerous com-
ments, including comments from drug testing laboratories
and companies supplying drug testing equipment on the
guidelines for drug testing promulgated by the Depart-
ment of Health and Human Services (DHHS). Many of
the commenters state that the certification requirements
for drug testing laboratories are too rigid because the
DHHS guidelines require laboratories to have the capa-
bility to do both initial and confirmation testing at the
same laboratory site. The Director of the Santa Maria
Public Airport District and Psychemedics Corporation, a
commenter at the San Francisco public hearing, suggest
that the FAA use analysis of hair, in lieu of urinalysis
testing, to test for drugs on the basis that hair analysis
may be more accurate and more reliable. Psychemedics
Corporation proposes that analysis of hair samples would
produce more complete results because hair contains a
“longitudinal” history of drug use that could reveal drug
use in excess of 90 days before analysis. This commenter
also notes that the two-step process of immunoassay and
GC/MS analysis would still be used; the only change
would be the material that was analyzed. Federal Express
strongly opposes implementation of the DHHS guidelines
because they are overly-burdensome on carriers with op-
erations in mulitple locations.
Some commenters also state that a split sample should
be obtained from each individual in order to ensure the
accuracy of the analysis. Sever2] commenters raise the
issue that specimens may be used by an employer to test
for physiological states, including epilepsy and pregnancy,
to discriminate against applicants and employees. A few
commenters consider the requirement of “‘monitored”’ speci-
men collection, whether by listening to or directly observ-
ing an individual, to be embarrassing and intrusive.
The AMA opposes the proposal to require employers to
comply with the DHHS guidelines. The AMA states that
these requirements would result in an undue hardship
RETF Oe a ee
po
En ee A
48a
on aviation medical examiners who must comply with
chain-of-custody procedures designed to ensure the integ-
rity of the specimen.
The NTSB strongly concurs in the requirement that
drug testing laboratories that analyze specimens pursuant
to the drug testing program must meet the scientific and
technical DHHS guidelines and must be certified by the
Department of Health and Human Services. Insofar as
the DHHS guidelines are inconsistent with other NTSB
comments, the NTSB recommends that the FAA revise the
guidelines for the industry drug testing program. ATA
agrees that only DHHS-approved labs should be used for
analyzing specimens but that the DHHS guidelines should
be tailored to accommodate the particular needs of the
aviation industry.
The SYVA Company and Drug Screening Systems, Inc.
submitted comments to the FAA on the DHHS guidelines.
Both companies are involved in the manufacture and sup-
ply of drug screening systems and equipment. These com-
panies urge caution in the FAA’s proposal to adopt the
DHHS guidelines based on the restrictive and possibly
burdensome nature of the requirements on employers re-
quired to conduct drug tests pursuant to the rule. These
companies address several issues, including batch re-
quirements, on-site collection, threshold drug levels, and
development of new testing procedures not permitted un-
der the current DHHS guidelines.
IFFA feels strongly that the Xnzyme Multiplied Im-
munoassay Technique (EMIT) test should not be used
as part of laboratory analysis of specimens because the
test detects only the presence of a drug metabolite of the
active drug and it often results in false-positive results.
false-negative results, or misidentified results.
ALPA generally supports the proposal to make the
DHHS guidelines applicable to collection and analysis of
specimens. However, ALPA believes that the FAA’s reg-
44a
ulation should contain additional employee safeguards.
First, the regulation should require split samples during
collection. Second, the regulation should require that
threshold drug levels determined by a confirmation test be
consistent with the initial test to account for quantitative
discrepancies in test results that are not attributable to
deterioration of the sample. Third, ALPA suggests that
an employee should be able to present the results of an
independent test result to an MRO during review of test
results to determine the validity of a positive test result.
Fourth, the regulation should allow labor and manage-
ment, through collective bargaining, to inspect labora-
tories and to perform quality control and administrative
functior 3 related to any anti-drug program.
Labor unions, including TWU and the Teamsters Union,
advocate development and implementation of separate or
additional guidelines to safeguard the selection and per-
formance of laboratories analyzing specimens for drugs
or drug metabolites.
EEAC believes that the DHHS guidelines are a valuable
contribution to the goal of establishing procedural norms
in collection and testing of specimens. However, EEAC
believes that employers should establish individual pro-
cedures to ensure the integrity of a sample and its anal-
ysis. EEAC emphasizes that it is inappropriate for the
FAA to impose such detailed requirements on private
employers.
FAA Response. In the NPRM, the FAA proposed that
all collection of specimens and drug testing take place in
accordance with the “Mandatory Guidelines for Federal
Workplace Drug Testing Programs” published by the De-
partment of Health and Human Services (53 FR 11970;
April 11, 1988). The DHHS guidelines describe the col-
lection and testing procedures applicable to all drug test-
ing in the Federal government, and they include safe-
guards for the accuracy and privacy of collection and
testing.
45a
The Department of Transportation has determined
that certain modifications of the DHHS guidelines are ap-
propriate in the context of this and other DOT-operating
administration drug-free workplace regulations. The re-
sult will be the DOT “Procedures for Transportation
Workplace Drug Testing Programs,” which will be codi-
fied at 49 CFR Part 40. These DOT procedures are in-
tended to preserve, to the greatest extent praticable, the
important safeguards provided by the DHHS guidelines.
Some of the modifications to the DHHS guidelines will
be editorial in nature (e.g., references to responsibilities
of “agencies” are changed to references to “employers”).
Other modifications are intended to take into account dif-
ferences in the situations, of Federal agencies and DOT-
regulated industries. For example, in testing at remote
sites, DOT-regulated industries may find it necessary to
conduct come kinds of testing in medical facilities or
through the use of mobile units, rather than the more
permanent collection sites contemplated by the DHHS
guidelines. It may not be practicable for regulated em-
ployers to maintain on-site permanent logbooks. Conse-
quently, the DOT procedures would permit alternative
collection and recordkeeping procedures in these circum-
stances.
The Office of the Secretary in the Department of Trans-
portation will publish elsewhere in today’s Federal Regis-
ter an interim final rule with request for comments en-
titled, “Procedures for Transportation Workplace Drug
Testing Programs,” that will codify the Department of
Health and Human Services guidelines for drug testing
at 49 CFR Part 40. This new part will set forth require-
ments for such things as specimen collection procedures,
laboratory procedures, and quality assurance and certifi-
cation procedures. The rule will provide guidance on how
this rule shall be implemented.
During the comment period on the FAA’s NPRM, and
those rules proposed by other DOT operating administra-
46a
tions, comments were received concerning the DHHS
guidelines. These comments are noted in this preamble
and also will be transferred to the Department of Trans-
portation to be incorporated in the docket for the Office of
the Secretary (OST) interim final rule creating 49 CFR
Part 40. OST will respond te those comments, as well as
comments received during the comment period for Part
40, in its notice following the end of that comment period.
The FAA proposed only urine testing in the proposals
contained in the NPRM. The suggestion of drug testing
using analysis of hair specimens raises an issue within
the expertise of the Department of Health and Human
Services. Thus, at this time, DOT and the FAA do not
intend to deviate from urinalysis as the technique for
determining the presence of drugs or drug metabolities in
an employee’s system.
The FAA acknowledges the AMA comments regarding
the inability of all aviation medical examiners to comply
with the collection and chain-of-custody procedures con-
tained in the DHHS guidelines due to the lack of appro-
priate facilities for collection. The FAA does not agree
with the AMA that the requirements are overwhelming
or overly-burdensome. Although the AMA was not spe-
cific regarding its objection to the collection and chain-of-
custody procedures, DOT has included provisions in the
DOT procedures to address some of the difficulties associ-
ated with collection and chain-of-custody procedures that
may not have been appropriate for private entities. How-
ever, the FAA and DOT believe that strict collection and
chain-of-custody procedures are critical to ensure the in-
tegrity and identity of a specimen provided by an em-
ployee. Thus, DOT has retained these protections in its
modification of the DHHS guidelines. Moreover, only
those aviation medical examiners who choose to provide
this service to commercial aviation personnel during a
physical examination are required to conform to the mini-
mum procedures cortained in the DOT procedures.
47a
Consistent with the suggestion of the NTSB and other
commenters, the Department of Transportation will
modify the DHHS guidelines to tailor the provisions for
application by private entities. The DOT procedures wil!
not modify the basic, technological aspects of the rule
(e.g., DHHS certification of laboratories, testing method-
ologies, collection procedures, and chain-of-custody pro-
cedures). Any arguably substantive changes from the
DHHS guidelines will be included only to reduce prac-
tical and administrative burdens on private entities. These
changes will be discussed in an ancillary document pub-
lished by the Department of Transportation in the Federal
Register. DOT and the FAA believe that the DOT pro-
cedures will provide adequate and appropriate procedures
for collection and testing of samples. Although the FAA
anticipates that the DOT procedures will prove to be an
effective and efficient method of collection and testing, ex-
perience under the testing program or a change in the
circumstances or needs of the industry may warrant fur-
ther regulatory revisions in the future.
Accuracy of Drug Test Results. Many commenters base
their opposition to drug testing on the perceived inac-
curacy of analysis and test results. The commenters in-
clude the issues of false-positive test results, passive in-
halation of illicit drugs, misidentification of licit drugs,
and ingestion of food substances, including poppy seeds,
resulting in a positive drug test result.
FAA Response. The FAA is aware of these expressed
concerns because each of these issues surfaced in the early
1980s with the first series of drug testing programs intro-
duced in the military and the private sector. In the early
years of drug testing and analysis, laboratory security
and analytical procedures had not reached today’s level of
sophistication. False-positive test results occur primarily
in analysis of a specimen during an initial screening test.
although contemporary screening tests, such as immuno-
assay tests, have become extremely accurate and approach
48a
99 percent accuracy levels. Despite its increased accuracy,
the initial screening test remains a less expensive test
used only to yield a preliminary indication of the possible
presence of drugs or drug metabolites. In order to ensure
the integrity and accuracy of any test result, each positive
initial screening test result must be confirmed using GC/
MS analysis or another confirmatory procedure that may
be subsequently approved by DHHS and incorporated into
the DOT procedures. The GC/MS confirmation test is an
extremely accurate and sophisticated test and is virtually
error-free when used in compliance with the DHHS guide-
lines. The DOT “Procedures for Transportation Work-
place Drug Testing Programs” (49 CFR Part 40), will
be essentially identical to the ““Mandatory Guidelines for
Federal Workplace Drug Testing Programs” published
by the Department of Health and Human Services on
April 11, 1988.
Employers must comply with the DOT procedures when
conducting a testing program pursuant to the final rule.
Like the DHHS guidelines, the DOT procedures will pro-
vide a system of checks and balances during collection and
analysis of specimens. This system ensures the integrity
and accuracy of the tests using appropriate. scientific
methods and rigid chain-of-custody procedure. An em-
ployer may only use a laboratry that complies with the
DOT procedures. Also, an employer may only use a labor-
atory that has been certified by DHHS to process and
analyze specimens required by the FAA rule. The DOT
procedures regarding testing methodologies and- technical
matters will be identical to the DHHS guidelines. Thus,
employers will be able to use any DHHS-certified labora-
tory since the laboratories will not tiecessarily be required
to use different analytical techniques and testing method-
ologies for different entities conducting testing. The De-
partment of Transportation expects that sufficient labora-
tories will have been certified for drug analysis by the
Department of Health and Human Services by early
49a
1989. However, the FAA will extend the compliance dates
contained in this final rule if DHHS has not certified a
sufficient number of laboratories to efficiently and accu-
rately process and analyze specimens pursuant to the re-
quirements of this final rule.
Since the mid-1980s, laboratories have become increas-
| ingly sophisticated in their analytical methods and chain-
t of-custody procedures. Many laboratories have compiled
4 extensive records demonstrating scientific accuracy and
f protection of individual specimens. For example, Compu-
Chem Laboratories, a major drug testing laboratory, has
analyzed over 500,000 urine samples, conducting discrete
testing for nine different drugs which resulted in nearly
five million distinct analyses of these specimens, since
1980. CompuChem also has analyzed approximately
- 750,000 urine samples for the presence of two different
drugs, resulting in nearly 1.5 million analyses of these
specimens, pursuant to its contract with the military.
None of the over six million analyses performed for DOT,
the military, and other private and public entities has
resulted in a false-positive test result.
In late 1987, a CompuChem clerical worker incorrectly
labeled two samples that belonged to DOT employees.
Within hours after the test results were questioned by the
medical review officer, CompuChem and the medical re-
view officer had identified and corrected the error. Compu-
Chem was not satisfied with its prompt resolution of the
error. As stated in its comment to the NPRM, Compu-
Chem has instituted an additional system of review, by
CompuChem personnel and computer checks, to ensure
that “* * * this one in a million error will not reoccur.”
Another drug testing firm, PharmChem Laboratories,
has conducted over eight million nonmilitary drug tests
nationwide. In its statement to the FAA during the
public hearing held in San Francisco on June 9, 1988,
PharmChem notes that several courts have determined
that the GC/MS confirmation test is “virtually 100 per. .
50a
cent accurate, assuming that proper chain-of-custody pro-
cedures are followed.”
The FAA does not believe that the issue of “passive
inhalation” of marijuana smoke will prove to be a sig-
nificant issue leading to false-positive test results. First,
PharmChem’s statement indicates that the DHHS thresh-
old levels that would result in a positive drug test result
for the presence of marijuana or marijuana metabolites
(to be incorporated completely and without change in the
DOT procedures) are set at a level sufficiently high to
preclude the possibility of a positive test result based on
passive inhalation of marijuana smoke. Second, studies
conducted to simulate the conditions that result in passive
inhalation have been conducted in artificially-devised and
extremely confining areas that were poorly ventilated.
Also, in order to obtain a positive test result, testing was
conducted immediately after this prolonged and intensive
exposure to the marijuana smoke. Based on the FAA’s
knowledge of these studies, the FAA has concluded that
it is highly unlikely that the identical circumstances would
be encountered or accurately reproduced outside a la-
boratory.
Finally, the FAA believes that the safeguards that will
be provided in the DOT procedures and by the medical
review officer (MRO) review process, which are essen-
tially identical to the DHHS guidelines, will preclude mis-
identification of food substances or licit drugs that might
produce a false-positive test result. The DOT procedures
will provide an individual with an opportunity to report
any legal or prescription drugs that he or she may be
taking at the time of collection of the specimen. The
MRO’s broad authority to interpret each confirmed posi-
tive test result, to evaluate an employee based on the
MRO’s knowledge of drug abuse disorders, and to verify
that a confirmed positive test result is accurate should
preclude misidentification of food substances or licit drugs
taken in accordance with a valid prescription. In sum-
5la
mary, the FAA believes that the two-step testing process,
coupled with the DOT procedures, provides a process by
which an individual is protected from erroneous false-
positive drug test results.
Preemployment Testing. Most organizations and indi-
viduals do not object to the concept of preemployment test-
ing. AOPA supports preemployment testing at the dis-
cretion of the employer. Operators who hire pilots or
crewmembers pursuant to short-term contracts believe
that a preemployment test is burdensome if required each
time a pilot is rehired pursuant to a new contract. These
entities suggest that preemployment tests be given only
at the time of training or placement on a bid list for
contracts.
Suburban Airlines has required preemployment testing
of all flight crew applicants for over a year. Suburban
supports 100 percent preemployment testing of the avia-
tion employees proposed in the NPRM. The Director of
the Santa Maria Public Airport District also supports
preemployment testing and suggests that preemployment
testing be implemented immediately.
The Soaring Society of America (SSA) believes that
small business employers should have the option of re-
quiring preemployment drug testing as a condition of
employment. SSA feels that preemployment testing should
be optional because applicants can circumvent detection
in a preemployment drug test merely by abstaining from
drug use for a short period of time before the pre-
employment test.
FAA Response. The FAA believes that preemployment
testing is a necessary component of an effective anti-
drug program. Pursuant to the rule, a preemployment
drug test is required only when an applicant has been
selected for employment in a sensitive safety- or security-
related position with the employer. The preemployment
testing provision does not require an employer to test each
52a
aprlicant for a sensitive safety- or security-related posi-
tion. The rule simply states that an employer may not
hire an applicant to perform sensitive safety- or security-
related functions unless the applicant has passed a drug
test. Therefore, the employer need only test an applicant
before actually hiring the applicant for a sensitive safety-
or security-related position.
The FAA has revised the proposed rules in ways which
should ease the burden on operators who frequently re-
hire employees pursuant to short-term contracts. The
FAA believes that the central issue regarding the fre-
quency of preemployment testing is the continuity of an
employee’s involvement in an employer’s drug testing
program. An employer is required to conduct a pre-
employment test only the first time that an employee is
hired pursuant to a contract with that employer so long
as the individual remains in the employer’s program, even
during periods between contracts. The individual, thus,
would be subject continuously to drug testing. In addi-
tion, so long as an employee is subject to an FAA-
approved anti-drug program, another employer may use
that employee to perform sensitive safety- or security-
related functions. Thus, an individual who participates
through a consortium would be able to provide services
on a contract basis to multiple employers without having
to submit to subsequent preemployment tests or to par-
ticipate in another employer’s drug testing program. If
an employee has not been continuously subject to an
FAA-approved anti-drug program, an employer would
be required to conduct a preemployment drug test.
In the FAA’s opinion, it would be permissible for an
employer to allow a contract employee to continue in the
employer’s anti-drug program after termination of a
contract. Particularly in the case of an employer who
hires employees pursuant to a series of short-term con-
tracts, both the employer and the employee benefit if the
employee is continuously subject to a drug testing pro-
58a
gram. The employer could “rehire” the employee at any
time but would not be required to give the employee an-
other preemployment drug test. In addition, the employee
could perform sensitive safety- or security-related func-
tions for another employer on a temporary basis but
would not be required to participate in another employ-
er’s anti-drug program or to submit to anti-drug pro-
gram or to submit to another preemployment drug test.
To the extent that the employee is not covered by an
FAA-approved anti-drug program, an employer would be
required to conduct a preemployment drug test before the
employee could be hired by a subsequent employer or re-
hired by a previous employer.
Periodic Testing. AOPA believes that periodic drug
testing should not be part of an employer’s drug testing
program but should only be conducted based on the rea-
soned judgment of an aviation medical examiner. RAA
supports periodic testing during medical certification at
least once each calendar year. RAA believes that the em-
ployee should bear the cost of the periodic test. Federal
Express does not oppose periodic testing but believes that
it should be unrelated to the FAA medical examination.
The AMA opposes periodic drug tests as part of a
routine medical examination because compliance with col-
lection and chain-of-custody procedures, such as those con-
tained in the DOT procedures and the DHHS guidelines,
would be an undue burden on aviation medical examiners.
ATA stated that its association is not convinced that
periodic testing effectively deters illicit drug use because
of the relative ease with which this test can be circum-
vented by abstinence. SSA generally does not endorse
periodic testing because an employee can avoid detection
by relatively short-lived abstinence before any announced
periodic test.
FAA Response. The FAA agrees with the commenters
that announced periodic testing can be circumvented by
54a
an employee’s abstinence from drug use. However, peri-
odie testing does enable an employer to identify those
employees who are so heavily-dependent on drugs that
they are unable to abstain from drug use for even a short
period of time prior to a periodic test.
The FAA has modified the periodic testing require-
ment of the regulation. Under the proposed regulation,
an employee who holds a medical certificate would have
been required to submit a specimen for drug testing as
part of each medical examination required pursuant to
Part 67. The revised section makes it clear that an indi-
vidual is required to submit a specimen for drug testing
during the first medical examination of the employee dur-
ing the calendar year after implementation of the anti-
drug program. Therefore, pilots who hold Class I medi-
cal certificates, who are required to have periodic medical
examinations at 6-month intervals, must be tested only
once during one of the medical examinations of the year
pursuant to the anti-drug program.
The revised section also states that an employer may
discontinue periodic testing after the first year of pro-
gram implementation when the employer has implemented
its random testing program according to the implementa-
tion schedule and, therefore, is conducting a significant
number of random tests. The periodic testing require-
ment will ensure that all current employees who hold
medical certificates will be tested once during the first
year of implementation of an employer’s anti-drug pro-
gram; most of the employees who hold medical certificates
also will be subject to random selection for testing during
part of the first year of implementation. The majority
of random testing programs will be operational after the
first year of implementation and periodic testing, which
is less effective than random testing, will no longer be a
necessary component of an employer’s anti-drug program.
The FAA anticipates that these revisions will provide
maximum drug detection capability and ease the transi-
55a
tion to a full random testing program. The FAA con-
siders the revision to be appropriate to relieve some of
the significant economic and administrative burdens noted
by the commenters who believe that periodic testing is an
ineffective and ineffective drug deterrent.
Random Testing. Most individual commenters oppose
random testing for a variety of reasons. Among these
reasons is the lack of evidence of drug use or abuse in
aviation to warrant random testing, invasion of indi-
vidual privacy, and violation of constitutionally-protected
rights.
AOPA opposes random testing primarily on the basis
of the unsettled constitutional issues surrounding random
testing and the burden imposed by this testing method on
law abiding citizens. AOPA suggests that the FAA delay
promulgation of a final rule until the issues raised by
random testing are substantially resolved by the Supreme
Court in Railway Labor Executives’ Association v. Burn-
ley and National Treasury Employees Union v. von Raab
(cited previously). AOPA states that, by awaiting any
Supreme Court decision, the FAA could ensure that the
final rule is in conformity with guidance enunciated in
the Supreme Court’s opinion in Burnley and von Raab.
One commenter submitted comments individually, as na-
tional litigation counsel for AOPA, and on behalf of the
California Aviation Council and the Orange County
Aviation Association. This commenter states that the
NPRM is an unconstitutional invasion of privacy and a
violation of an individual’s procedural due process rights.
The commenter believes that the NPRM should be with-
drawn to await the Supreme Court’s impending decisions.
The AMA supported random testing only as part of
a comprehensive rehabilitation program. The AMA be-
lieves that random testing is not cost effective, is un-
necessarily intrusive, and, without confirmation testing,
random screening tests are inaccurate.
i
'
:
}
|
:
4
;
J
*
q
{
4
:
‘
:
56a
In addition to soliciting comments on the general con-
cept of random testing, the FAA solicited comments on an
appropriate random testing rate of up to 125 percent.
Several small business entities, including TEMSCO Heli-
copters, Inc., Henson Airlines, and Tramco, Inc., oppose
the random testing requirement based on the financial
and administrative burdens associated with a 125 percent
testing rate, transportation of employees to the collection
site, and replacement of personnel during testing.
TEMSCO Helicopters suggests that a random testing
rate of 10 percent will enabie the industry to determine
if there is a drug problem in aviation without overburden-
ing the industry. RAA also believes that a 125 percent
random testing rate is overreaching and unwarranted;
however, if the FAA proceeds with a random testing
provision, RAA suggests that a 50 percent random test-
ing rate is appropriate. Although Suburban Airlines
strongly supports random testing, Suburban believes that
a 50 percent random testing rate of the employees pro-
posed in the NPRM would relieve the unjustifiable eco-
nomic burden on a cost-benefit basis. ERA Aviation, Inc.,
a Part 121 and Part 135 certificate holder operating more
than 12 helicopters and 12 airplanes, believes that un-
announced random testing is the most effective deterrent
to drug abuse. However, ERA questions a requirement
to randomly test 125 percent of the employees on an an-
nual basis. ERA believes that random testing of 25
percent to 50 percent of the affected employee groups,
coupled with periodic testing, would provide a sufficient
deterrent to drug use if the penalties for positive test
results were severe.
NTSB opposes the random testing requirement of the
proposed rules. However, if random testing were included
in the final rule, the NTSB believes that a relatively high
random testing rate would be a more effective deterrent
to drug use. The acting Chairman of the NTSB did not
concur with the NTSB’s position regarding random test-
57a
ing; the acting Chairman supports random testing pro-
vided that the random testing rate is sufficiently high to
serve as a deterrent to drug use.
ATA, American Airlines, and Delta Airlines support
the FAA’s mandatory random testing provision because
it would provide the maximum deterrent effect to illicit
drug use. ATA supports a random testing rate of 50
percent based on a review of Department of Defense and
private industry drug testing programs. American Air-
lines also supports the mandatory random testing provi-
sion and a 125 percent random testing rate. A consultant
to American Airlines on the issue of drug abuse preven-
tion in the workplace, who submitted an affidavit attached
to comments by American Airlines, is convinced that ran-
dom drug testing is “the only powerful and proven means
of detecting drug use and drasticaily reducing drug use
and thereafter preventing further drug problems from oc-
curring.” On the other hand, Federal Express states that
random testing should be permitted, but not mandated,
by regulation. Federal Express states that if the FAA
ultimately mandates random testing, carriers should be
allowed to choose a random testing rate between 15 per-
cent and 50 percent. Federal Express also believes that
carriers should be free to set different random testing
rates for different groups of employees.
There was almost universal opposition to random test-
ing by unions and organizations representing employees.
ALPA, the Transport Workers Union of American
(TWU), and the International Brotherhood of Teamsters
(Teamsters Union) are ‘adamantly opposed to random
testing. ALPA (Council #12) concurs in ALPA’s gen-
eral opposition to random drug testing of professionals
in the aviation industry. The Teamsters Union states
that a drug testing program is a change in working con-
ditions which, in accordance with Federal labor law, is a
mandatory subject of collective bargaining.
ait ID tate
58a
SSA does not oppose random testing of employees. How-
ever, in order to provide a workable and effective anti-
drug program for small business, SSA suggests that en-
tities employing 12 or fewer full-time employees be ex-
empted from the random testing requirement. SSA de-
fines “full-time employees” as those individuals who work
for an employer at least 30 hours per week or 5 days per
week and have maintained that schedule for at least 90
days.
One commenter, who spoke at the San Francisco public
hearing on June 9, 1988, has been a practicing physician
for 24 years and has devoted the past seven years to the
exclusive practice of aviation medicine. This commenter
has worked regularly with EAP representatives and has
been involved with “* * * hundreds of airline employees
before, during and after treatment for drug and alcohol
dependencies.” Based on the commenter’s extensive ex-
perience in drug and alcohol use by aviation employees,
he observes that the present system of relying on “* * *
peer and supervisory identification, and a highly visible
employee assistance program,” and on a scheme of “pre-
employment for-cause and fitness-for-duty drug testing,
enables significantly impaired employees to remain in the
workforce.” Therefore, this commenter concludes that in
order to eliminate those remaining risks, “* * * there is
nothing more we can do short of random testing.”
FAA Response. While noting the constitutional issues
surrounding the issue of random testing discussed pre-
viously, the FAA continues to believe that unannounced
testing based on random selection is a fundamental com-
ponent of an effective drug testing program. Unan-
nounced, random testing has proven to be an effective de-
terrent to drug use and will provide safety benefits to the
aviation community by reducing or eliminating drug use
by sensitive safety- or security-related aviation personnel.
Unannounced, random testing programs initiated by the
military, including the Coast Guard, and private indus-
59a
try show declining drug use, evidenced by a decrease in
the number of individuals who test positive for drugs,
over the course of the drug testing program.
The FAA received many comments regarding the pro-
posed random testing rates. Several commenters suggest
a random testing rate of 125 percent because that rate
would result in the most significant deterrent to drug use
in the aviation industry. However, other commenters who
address this issue believe that a 125 percent random test-
ing rate would be excessive and would impose a significant
economic burden, particularly on small aviation businesses.
The commenters propose a range of random testing rates
starting at 10 percent annually. The majority of the
commenters suggest that an annual 50 percent random
testing rate for the aviation industry is appropriate. These
commenters believe that the 50 percent testing rate ac-
complishes several goals consistent with the intent of the
proposal.
In response to the commenters, the FAA has substan-
tially revised the random testing proposal in the NPRM
in order to reduce the practical and administrative bur-
dens associated with initiating an unannounced testing
program based on random selection of employees. The
FAA’s approach also is designed to provide a random
testing rate that balances cost effectiveness and burdens
on employees and employers but still results in an effec-
tive and credible deterrent to drug use.
For some employers, particularly those with a large
number of employees subject to drug testing, it may be
a substantial burden to move from no random drug test-
ing of employees directly to random testing of 50 per-
cent of the covered employees. For example, if required
to have tested 50 percent of all covered employees by the
end of the first year, employers might have to test at
rates far above a 50 percent rate toward the end of the
year, to make up for lower rates at the beginning of the
year. Employers should be permitted to start the pro-
oor
60a
gram at a lower testing rate and work up to a 50 per-
cent rate as experience is gained and the testing proce-
dure becomes administratively routine. The FAA does
not want te create a situation which might lead to in-
advertent © takes by requiring initial unannounced test-
ing based, -andom selection at too high a rate.
The final rule, therefore, provides an implementation
procedure that would allow employers to phase in unan-
nounced drug testing based on random selection of em-
ployees during the first 12 months in which tests are
required to be conducted. Employers would not be re-
quired to reach an annualized rate of 50 percent until
the last test collection of the first year of the program.
The total number of unannounced tests based on random
selection of employees during the first 12 months of the
employer’s testing program would have to equal at least
25 percent of the covered employee population. Also, the
employer is required to space the tests reasonably
throughout the year. This approach will provide a suffi-
cient level of deterrence to drug use and will permit the
employer to phase in the 50 percent rate.
Suppose, for example, that an employer has 1000 sensi-
tive safety- or security-related employees. At a 50 per-
cent annual rate, the employer would be required to con-
duct 500 unannounced tests based on random selection
during a year. Under the phased approach, however, the
employer could conduct only a few drug tests at the
beginning of the program and then gradually increase
the number of tests until, by the end of the first year,
the annualized rate of 50 percent was achieved. Thus, if
the employer’s drug testing plan contemplated adminis-
tration of unannounced tests based on random selection
on 12 occasions during the year, the employer would
need to collect 42 urine specimens for analysis (500
divided by 12) on the last occasion, bu* could collect
fewer specimens until then. Overall, the employer would
have to collect at least 250 specimens for analysis during
6la
the first year. In subsequent years, the employer is re-
quired to maintain the 50 percent annualized rate for
unannounced testing based on random selection of
employees.
The FAA believes that the final rule provides a moder-
ate, but substantial, level of testing based on random
selection that enables an employer to increase random
testing gradually during the first year of program im-
plementation. During subsequent years of the program,
the employer must maintain an annualized rate of 50
percent of the covered employees. In order to determine
the appropriate number of employees that must be tested
to reach the appropriate “annualized rate” for the ran-
dom testing program, the employer shall refer to the
number of employees subject to the rule at the beginning
of a calendar year.
At this time, the FAA believes that this phased pro-
gram, ultimately reaching a testing level equivalent to
50 percent of the covered program, ultimately reaching
a testing level equivalent to 50 percent of the covered
employees, will provide a sufficient deterrent to drug use
without imposing an undue economic or administrative
burden on employers and employees subject to the re-
quirements of the regulation. In addition, the program
will produce a sufficient data base at different annualized
rates and testing levels for the FAA to analyze the scope
of any drug problem in the commercial aviation industry
generally or within any particular sector of the commer-
cial aviation community. Analysis of the random drug
testing data submitted by an employer will allow the
FAA to determine if the random testing program should
be revised in any manner.
The phased program and the final 50 percent random
testing rate is consistent with the random testing pro-
gram currently applicable to safety- and _security-
sensitive employees of the Department of Transporta-
tion. DOT’s random testing program began in Septem-
62a
ber 1987; the random testing rate has gradually in-
creased and will reach an annualized rate of 50 percent
by October of this year. Data from September 1987 to
the present show that the current detection rate found
as a result of DOT’s random drug testing program is
0.83 percent; data from February 1987 to the present
show that the current detection rate for FAA and DOT’s
periodic (eg., scheduled) testing program is 0.012
percent.
According to the provisions of the final rule, all em-
ployers are required to randomly select a sufficient num-
ber of employees to enable the employer to conduct un-
announced testing of employees who perform sensitive
safety- or security-related duties for the employer at the
appropriate rate during the calendar year. In order to
conduct enough tests to reach the required percentage,
an employer may be required to select a number of em-
ployees who perform a sensitive safety- or security-
related functions for unannounced testing that is in ex-
cess of the actual number to meet the required percent-
age. Selection of a greater number of employees enables
the employer to reach the appropriate annualized rate
despite absences due to vacations and medical leave or
absences due to an inabil?ty to reach a collection site
resulting from travel or duty requirements.
If a consortium has been established among employers
or operators, the consortium would be required to select
and to test the appropriate rate of the aggregate total of
employees subject to the final rule who are covered by
the consortium. The testing rate of the consortium will
be attributed to each employer participating in the con-
sortium. In the FAA’s opinion, the consortium’s testing
rate can be attributed to each participating employer,
although less than the appropriate percentage of the
employees of a particular employer has been tested dur-
ing a calendar year, without significantly decreasing the
deterrent effect of a random testing program. An em-
63a
ployer or consortium that develops a random selection
scheme involving preliminary selection criteria, such as
ical zones, must specify these schemes or varia-
tions in the employer’s anti-drug plan. The FAA realizes
that these variations may provide administrative ease for
an employer. However, the FAA must review these
variations to ensure that the scheme does not dilute the
required annualized rate required by the final rule.
The FAA received comments from small aviation busi-
nesses regarding the difficulty of testing a large number
of employees on a random basis during the first year of
implementation of the rule. In response to these com-
ments, the FAA substantially revised the provisions of
the proposed rule. Certain Part 135 certificate holders
whose total workforce indicates 11 to 50 sensitive safety-
or security-related employees are given additional time
to submit a random testing plan and to ensure that the
appropriate percentage of the sensitive safety- and
security-related employees are subject to unannounced
drug testing on a random selection basis during a calen-
dar year. The FAA encourages these employers to de-
velop a comprehensive random testing plan as soon as
possible. As discussed later, Part 135 certificate holders
that employ 10 or fewer covered employees and those
individuals or entities listed in § 185.1(b), who are other-
wise exempt from the requirements of Part 135 but are
included in the final rule because they are engaged in
operations for compensation or hire, are given additional
time to develop and implement an anti-drug program
that includes random testing. The FAA notes that the
final rule does not restrict the ability of these employers
to submit a random testing program, and to implement
that program, earlier than the timeframes contained in
the final rule.
Some commenters address the issue of the difficulty in
developing an efficient and successful random testing
A i i ete
64a
program. The FAA notes that the rule provides flexi-
bility to an employer to begin the random testing pro-
gram at a lower random testing rate so long as the
required percentage of covered employees have been se-
lected on a random basis and have been tested by the
end of the first year after approval of the employer’s
anti-drug program or random testing plan. For exam-
ple, an employer may test small increments of employees
at the beginning of a period and may test a large per-
centage of employees at the end of the same period to
achieve the annualized rate that is required by the final
rule.
Postaccident Testing. AOPA supports postaccident
testing if it is conducted by the NTSB. AOPA believes
that postaccident testing should not be a part of an em-
ployer’s drug testing program and should not be con-
ducted by the FAA.
The NTSB comments that the 24-hour period pro-
vided for postaccident testing is excessive. The NTSB
recommends that the FAA specify a maximum period
of four hours for collection of a postaccident drug test
and provide an appropriate penalty for failure to collect
the specimen within the 4-hour period. The NTSB be-
lieves that delays of more than four hours in sample
collection impair detection of a drug and its “psychoac-
tive component(s)” in blood samples, particularly sub-
stances such as cocaine, marijuana metabolites, some
amphetamines, and phencyclidine (PCP). The NTSB
also suggests that blood testing is the preferable method
for postaccident testing and suggests that the FAA per-
mit this method of testing for the presence of drugs after
an accident. ATA also suggests that postaccident testing
should be conducted within 4 hours after an accident
and, in no case, later than 12 hours after an accident.
ATA recommended that the NTSB’s definition of ‘“‘in-
cident” should be added to the postaccident testing pro-
vision to cover situations when an aircraft is empty or
654
when personal injury or physical damage is less severe
than specified in the postaccident testing provision. ATA
also believes that postaccident testing should be con-
ducted unless a supervisor determines that an employee’s
drug use was not a contributing factor in the accident.
FAA believes that postaccident testing is “wasteful and
intrusive” unless the accident clearly is caused by the
person to be tested and there is individualized probable
cause to believe that the employee was impaired at the
time of the accident.
SSA does not completely endorse postaccident testing
based on a variety of practical considerations that SSA
believes are unresolved in the regulation as proposed.
However, SSA states that postaccident testing, after an
NSTB-defined accident, of any employee working for a
small business should be conducted as deemed feasible by
the employer. SSA believes that postaccident testing
should be conducted within 24 hours if the employer de-
termines that testing is feasible and appropriate. Also,
if the employer determines that testing is not feasible,
the FAA may request an explanation from the employer
during the routine investigation of the accident.
FAA Response. In the NPRM, the FAA proposed that
postaccident tests be conducted within 24 hours after an
accident based on the possibility that difficulties may arise
after an accident in transporting an individual to a col-
lection site or bringing a drug testing kit to the scene of
the accident. The FAA is aware that extended delays in
sample collection and testing after an accident may re-
sult in deterioration or elimination of a drug or a drug
metabolite from a person’s system. Recognizing these dif-
ficulties and concerns, the FAA has modified the post-
accident testing provision. Under the final rule, an em-
ployer must conduct postaccident testing of an employee
as soon as possible after the accident but in no case later
than 32 hours after the accident. Selection of this time
period comports with the DOT’s postaccident drug test-
66a
ing program for DOT employees, which provides a maxi-
mum of 8 hours to determine if an employee is required
to be tested and an additional 24 hours to actually ob-
tain a sample for testing.
The FAA strongly encourages employers to promptly
determine if an employee is subject to postaccident test-
ing, particularly in cases where there is little or no un-
certainty that an employee’s performance was a con-
tributing factor in the accident. The FAA intends to
vigorously enforce the regulation where there is unreason-
able delay in determining whether an employee should be
tested under this provision or where there is unreasonable
delay in testing after the determination to test is made.
Although several commenters who address the issue sug-
gest time periods of less than 24 hours, it is the FAA’s
opinion that a maximum period of 32 hours is a workable
and reasonable accommodation that is appropriate for the
aviation industry.
The NTSB’s suggestion that the FAA require an em-
ployer to conduct postaccident testing within four hours
after an accident is based on the time-sensitive nature of
toxicological testing of blood samples. On the other hand,
urinalysis testing does not involve the extreme time-
critical considerations associated with collection and test-
ing of blood samples. In the FAA’s opinion, postaccident
urinalysis testing is sufficient at this time to provide an
indication of an individual’s drug use that may have
been a causal factor in an aviation accident.
Also, the FAA proposed only urine testing in the
NPRM, specifically excluding blood testing as an option,
for all drug tests that would be conducted under the anti-
drug program. Therefore, the FAA considers the NTSB’s
suggestion to be beyond the scope of the notice and the
FAA has not adopted NTSB’s suggestion to permit post-
accident testing by collecting a blood sample. In the
aviation context, the significant proportion of serious ac-
cidents involving fatalities to crewmembers provides data
67a
with respect to drug involvement in those accidents. In
the FAA’s judgment, extending full toxicological testing
to surviving crewmembers is not warranted at this time.
Presently, the FAA is not convinced that including
the NTSB’s definition of “incident” as a trigger for drug
testing is warranted. As discussed below, the FAA be-
lieves that the revisions to the section providing for test-
ing based on reasonable cause will adequately address
circumstances that might qualify as “incidents.” The
current provisions allow sufficient, but limited, latitude
to an employer to determine whether an employee should
be tested following an incident or an accident not cov-
ered by the NTSB’s definition of accident.
Although several commenters suggest that the FAA
expand the scope of the postaccident testing provision,
the FAA believes that the postaccident testing provision,
limiting testing to only those employees whose perform-
ance may have been a cause of the accident, is appropri-
ate. The FAA believes that it is inappropriate to require
postaccident testing of an employee whose performance
could not have been a cause of the accident merely be-
cause that employee happens to have been onboard or in-
volved with an aircraft involved in an accident.
Testing Based on Reasonable Cause. The NTSB sug-
gested that the FAA include “incidents,” as defined by
the NTSB’s rules, as events that would trigger reason-
able cause testing. RAA agrees with the requirement
that two supervisors, one with training in the symptoms
of drug abuse, must concur in the decision to test an
employee based on reasonable suspicion of drug use.
RAA believes that each carrier should determine the
conditions which constitute reasonable suspicion. FEIA
also believes that two supervisors, trained to detect symp-
toms of drug abuse, must concur in all decisions to test
based on probable cause. ATA suggests that only one
supervisor be required to trigger testing an an employee
based on reasonable cause. In addition, ATA states that
68a
supervisors should not be required to have specialized
training for the purpose of determining when reasonable
cause exists to test an employee.
Tramco, Inc. believes that the proposed circumstances
that would support a decision to test based on reasonable
cause are too restrictive. Tramco believes that an em-
ployee’s attendance patterns, tips from coworkers, “error
rates,” and other indirectly observable indications should
also trigger testing based on reasonable cause. Tramco
currently uses these triggers in its drug testing pro-
gram; Tramco believes that the FAA’s criteria will not
result in detection of possible drug users because it is
limited to physical and observable indices of gross im-
pairment. SSA supports “for-cause” testing, as the em-
ployer deems necessary and feasible, if testing is con-
ducted pursuant to the DHHS guidelines.
IAM and TWU believe that the criteria that would
trigger testing based on reasonable cause are ill-defined.
These organizations believe that testing based on reason-
able cause will be a tool for employee harassment; these
organizations suggest that supervisory personnel should
be trained to recognize the symptoms of drug impair-
ment or that at least one of the supervisors making the
determination to test should be someone other than the
employee’s immediate supervisor. The Teamsters Union
and IAM believe that decisions and determinations re-
lated to testing based on reasonable cause should be docu-
mented and supported in a written report.
The Newton Psychological Centre submitted a “basic
identification profile,” developed to aid supervisors of the
Philadelphia Electric Company in identification of em-
ployees who may not be fit for duty. The profile is used
to detect early warning signs of problems based on medi-
cal or psychological problems. The profile sets forth be-
havioral, emotional, physical, biological, and cognitive
cues related to the use of marijuana, cocaine, alcohol,
barbiturates, am;yhetamines, and heroin, or cues related
SO ae Les ee ed
69a
to anxiety or depression. The company’s policies regard-
ing alcohol and substance abuse, job performance warn-
ing signs, and counseling and confrontation guidelines
are printed on the profile.
FAA Response. As stated in the FAA’s response to
comments submitted on the postaccident testing provi-
sion, the FAA is not including a “postincident” testing
provision at this time. However, the circumstances under
which a supervisor could require an employee to submit
to a test based on reasonable cause have been modified in
the final rule. Based on the comments submitted, par-
ticularly by employers who have existing “reasonable
cause” testing programs, the FAA has expanded the list
of circumstances that might trigger testing under this
provision. Evidence of repeated errors on the job, regula-
tory or company rule violations, or unsatisfactory time
and attendance patterns, if coupled with a specific, con-
temporaneous event that indicates probable drug use,
could provide additional, cumulative evidence to support a
decision to test an employee based on reasonable cause.
As proposed in the NPRM, an employer is permitted to
test a specimen provided by an employee, collected pursu-
ant to a reasonable cause determination, for the presence
of any drug or drug metabolite listed in Schedule I or
Schedule II of the Controlled Substances Act. The em-
ployer may test for these drugs, as part of the employer’s
approved anti-drug program, if the employer has specific
approval from the FAA to include these controlled sub-
stances in the employer’s anti-drug program. In addition,
the testing for these additional drugs must be conducted
in accordance with the DOT procedures to be codified in
49 CFR Part 40.
The FAA believes that the provision requiring two
supervisors, one of whom has specialized training in de-
tecting the symptoms of drug use, to concur in the deci-
sion to test an employee based on reasonable cause is
appropriate for large companies. However, the FAA has
70a
revised this section of the rule in order to address the
legitimate concerns of small employers, many of whom do
not have more than one supervisor employed at the com-
pany. For companies that employ 50 or fewer employees
who perform sensitive safety- or security-related function,
the rule specifies that only one supervisor is required to
make the determination that would trigger testing of an
employee based on reasonable cause. The FAA also has
clarified the annual EAP training requirements for super-
visors to make it clear that supervisors who make reason-
able cause determinations must have specific training that
will enable them to assess and demonstrate the basis for
testing based on reasonable cause.
Testing after Return to Duty. ATA believes that the
FAA should not set regulatory standards governing post-
rehabilitation testing. ATA, other employer and employee
organizations, and many individual commenters believe
that a schedule for postrehabilitation testing should be
made by management in consultation with persons in-
volved in an employee’s rehabilitation program. In order
to ensure continued disassociation from drugs, RAA sup-
ports a requirement for monthly screening, for 12 months,
after an employee has completed rehabilitation.
APFA believes that a schedule for postrehabilitation
testing should be determined by an employee’s EAP coun-
selor and should be limited to a reasonable period of no
more than one year. AFA states that decisions regarding
testing after rehabilitation should be the responsibility of
the individual treatment facility used by the employee.
FAA Response. The FAA agrees with the commenters
that suggest that unannounced testing during any rehabil-
itation and before an employee returns to duty should be
determined by the persons involved in the employee’s re-
hibilitation program. Decisions regarding the frequency
of testing during any rehabilitation program appropri-
ately lie with those individuals who are familiar with and
involved in any employee rehabilitation program.
Tla
However, unannounced testing after an employee re-
turns to duty is critical to ensure an employee’s continued
disassociation from drugs. The FAA believes that it is
essential to require unannounced testing of employees who
have returned to duty in a sensitive safety- or security-
related position for an employer after failing a drug test
given by an employer or after refusing to submit to a
drug test required by the final rule. This type of testing
is the most effective means of ensuring that an employee
remains drug free while performing commercial aviation
duties. Moreover, once an employee has returned to duty,
the FAA and the employer have a substantial interest in
requiring that employee to be drug free while performing
sensitive safety- or security-related duties in commercial
aviation. Therefore, the FAA has included a provision in
the rule requiring an employer to monitor an employee
who has returned to duty by providing unannounced drug
testing, pursuant to a schedule determined by the MRO,
for not more than 60 months after the employee has re-
turned to duty.
The rule also provides that an employer must conduct
unannounced testing of an individual who is hired to per-
form a sensitive safety- or security-related function after
failing a drug test or after refusing to submit to a drug
test for another employer and who has not previously
been subject to return-to-duty testing. This section of the
final rule addresses situations where an individual fails a
drug test or refuses to submit to a drug test but does not
return to duty for an employer. In this case, any subse-
quent employer would be required to test an individual
for not more than 60 months after the individual is hired
to ensure that the individual is drug free. In the FAA’s
opinion, if an employee failed a drug test given by a pre-
vious employer but returned to duty with that employer
in accordance with the requirements of this final rule, a
subsequent employer would not be required to reevaluate
a prior employer’s return-to-work decision. An employer
would be required to test this individual prior to employ-
72a
ment but would not be required to monitor the employee
after the employee was hired. Pursuant to the final rule,
the medical review officer (MRO) has the discretion to
determine the appropriate level of unannounced testing
for an individual or an employee. The FAA believes that
it is appropriate to allow the MRO to tailor the frequency
of this type of testing to adequately address differences
between individuals, the level and type of drug use, and
any treatment or counseling program.
The FAA notes that the MRO also is required to ensure
that an employee has been tested for drugs, in accordance
with the procedures in the final rule and the DOT pro-
cedures, before being hired or returning to duty. In most
cases, the MRO will not be required to arrange testing
for an employee because the employee will have taken a
drug test as part of any employee rehabilitation program.
However, the MRO must ensure that an individual or
employee has been tested, in accordance with the’ pro-
cedures of Appendix I to Part 121 and the DOT pro
cedures, before the MRO can make a recommendation that
an individual be hired or than an employee be returned to
duty after failing a drug test. In the FAA’s opinion, a
preemployment drug test would suffice to satisfy this re
quirement of the final rule.
Employee Assistance Programs and Rehabilitation. The
FAA sought comment in the NPRM regarding three dif-
ferent EAP options. These options specified the circum-
stances under which an employee would be given the op-
portunity to seek rehabilitation. Option 1 would allow all
employees to seek an opportunity for rehabilitation re-
gardless of how the employee’s drug use was detected.
Option 2 would allow most employees, except those em-
ployees whose drug use was detected as a result of post-
accident testing or testing based on reasonable cause, to
seek an opportunity for rehabilitation. Option 3 would
only allow employees who volunteer to seek rehabilitation
and would exclude all employees whose drug use was de-
73a
tected by any other means. Under all three options, an
employer would not be required to offer an opportunity
for rehabilitation or to provide job security to any em-
ployee who was identified as a drug user on the job.
Employer organizations tend to support the third op-
tion proposed in the NPRM regarding rehabilitation and
reemployment or job security opportunities that should
be offered to employees. Part 121 certificate holders,
as generally noted by ATA, support the third option. For
example, Delta Airlines believes that the most effective
deterrent to drug use is the threat of losing a job. On
that basis, Delta states that mandatory rehabilitation and
an opportunity for continued employment would diminish
the effectiveness of the rule. American Airlines disagrees
with ATA’s position and supports the first option. Fed-
eral Express supports the third option if the FAA man-
dates rehabilitation. The Helicopter Association Interna-
tional (HAI) states that requiring an employer-sponsored
rehabilitation program whenever required testing of an
employee produces a positive drug test result places an
unwarranted burden on the employer. HAI believes that
an employer should have the right to dismiss an employee
if any drug test conducted during employment produces
a positive test result. HAI states that the employer should
have the ability to decide which employees, based on the
‘“‘value” of the employee to the organization, would be of-
fered an opportunity for rehabilitation.
Small Part 135 certificate holders generally state that an
employer should have the right to fire any employee who
uses drugs and feel that an opportunity for rehabilitation
should not be offered to any employee who uses drugs.
These small employers base their position on the potential
liability to the company of rehiring a known drug user,
the expense to the company of holding the employee’s job
open, or replacing an employee on a temporary basis,
during rehabilitation.
74a
The AMA reaffirmed its long-standing support of em-
ployment-based treatment and assistance programs for
employees with alcohol or drug problems. The AMA be-
lieves that the FAA should require an employer to pro-
vide one opportunity for rehabilitation to any employee
who voluntarily enrolls in an EAP and to any employee
who is identified as a drug user through testing.
NTSB generally concurred in the concept of requiring
an employer to provide EAP services to employees. The
NTSB recommended that employers be required to offer
one opportunity for rehabilitation to employees who vol-
unteer for an EAP and for employees who are identified
as drug users through any type of drug testing.
Most small business entities, TEMSCO Helicopters,
Inc. and Overseas Air Transport Corporation for exam-
ple, object to a regulatory provision that would require
an employer to provide job security to an individual en-
rolled in rehabilitation. This objection is based on the
financial burden of keeping a job open for an employee
who is unable to perform his or her duties and the
elimination of an employer’s discretion to fire an em-
ployee who uses drugs. RAA believes that an employee
who has successfully completed rehabilitation, as deter-
mined by the head of the rehabilitation program and air-
line management, should be offered an opportunity to
return to duty. Executive Air Fleet (EAF), a Part 135
certificate holder with 200 employees subject to testing
would support job security for an employee who volun-
tarily sought rehabilitation and who had three to five
years of service with the company. SSA also believes
that an employee’s length of employment may be a rea-
sonable factor to consider when specifying an employer’s
obligation to retain or rehire as employee participating
in rehabilitation. SSA also states that holding an em-
ployee’s job open during inpatient rehabilitation will
greatly complicate small business operations for an un-
known time period. Henson Airlines states that, under
a Fam
75a
its existing program, employees will be fired as a result
of a positive alcohol or drug test. ERA Aviation, Inc.
strongly objects to any Federally-mandated rehabilitation
and rehire requirement. ERA Aviation objects to the
cost of providing EAP services, but more important,
objects to assuming the potential liability problems that
could result from rehiring a known user of illegal sub-
stances even if that employee has successfully completed
a rehabilitation program.
Several small operators, including TEMSCO Helicop-
ters, Inc., object to the requirement to provide an oppor-
tunity for rehabilitation to employees identified as drug
users. Henson Airlines provides an opportunity for re-
habilitation only to employees who voluntarily enroll in
rehabilitation. RAA supports these views. Organizations
such as the American Association of Airport Executives
(AAAE) and ATA believe that an opportunity should
be offered only to employees who volunteer for rehabili-
tation. SSA states that there should be no requirement
that a small business retain or rehire any employee who
tests positive for drugs as a result of any unplanned
drug test, including postaccident or for-cause testing.
ATA believes that limiting rehabilitation and reemploy-
ment to volunteers has the dual effect of making safety
the industry’s highest priority and containing the costs
associated with rehabilitation. AAAEF believes that any
employee who tests positive for drugs should be dis-
missed immediately. AAAE comments that employers
and employees should be free to negotiate broader re-
habilitation and reemployment rights as part of a col-
lective bargaining agreement.
. Labor organizations are strong supporters of broad
EAP opportunities and services. TWU and FEIA be-
lieve that all employees who test positive, regardless of
the reason for testing should be given at least one oppor-
tunity for rehabilitation. FEIA supports the require-
ment for at least one rehabilitation opportunity because
76a
a positive drug test is not proof of impairment on the
job. The Teamsters Union believes that negotiated,
client-specific rehabilitation programs should be avail-
able to employees who volunteer and for employees who
test positive on one occasion. Labor organizations com-
ment that all rehabilitation costs should be paid by the
employer either directly or as part of an employee bene-
fit or insurance package. TWU concurs with this posi-
tion, insofar as it relates to the first positive test result,
unless the employee has engaged in conduct that would
otherwise justify suspension or discharge under an ap-
plicable collective bargaining agreement.
ALPA states that there is no valid reason to limit
access to an EAP only to employees who volunteer for
rehabilitation. Based on experience in the HIMS pro-
gram, only 15 percent of the pilots treated for alcoholism
were self-referred; 85 percent of the pilots were discov-
ered by the union or management, or both. ALPA be-
lieves that rehabilitation should be made broadly avail-
able to any employee who could benefit from an EAP
and that, in some cases, a second opportunity for re-
habilitation may be appropriate. ALPA urges the FAA
to revise the proposed regulation to require employers to
pay the cost of rehabilitation programs that are man-
dated by the regulation.
ALPA believes that traditional EAP techniques that
are tailored to a specific population, such as the HIMS
program, will be more effective in deterring drug use
than the anti-drug program proposed in the NPRM.
During the 15-year period that the HIMS program has
been in effect, 800 pilots have participated in rehabilita-
tion for alcoholism yielding a long-term success rate of
93 percent. ALPA states that the average “off line time”
for pilots involved in the HIMS program is approximately
120 days: 30 days for treatment; 30 days for aftercare
treatment, observation, and processing; and 45 to 60
days for processing of an FAA application. The recov-
ee a ae Tees
77a
ery rate for pilots who particpate in one rehabilitation
opportunity is 85 percent. Of the 15 percent of the
pilots who suffer a relapse after the first treatment,
approximately 50 percent are successfully treated in their
second rehabilitation opportunity.
FAA Response. Most comments regarding rehabilita-
tion deal with the issue of whether, and under what cir-
cumstances, to offer rehabilitation and to provide job
security to an employee and the length of any employee
rehabilitation period. The FAA carefully considered the
various arguments submitted by the commenters on the
issue of EAP services and rehabilitation opportunities
for employees. The FAA understands, and considered,
the arguments raised in defense of broad rehabilitation
opportunities and job security for aviation personnel who
use drugs.
However, the FAA reviewed the two options that in-
cluded provisions providing broad rehabilitation oppor-
tunities and job security to employees whose drug use
was detected through testing under the final rule. Many
of the commenters oppose rehabilitation opportunities
and job security for employees who fail to discontinue
drug use and wait to be detected by testing. The FAA
agrees with these commenters and believes that a strong
message must be conveyed to drug users that the use of
drugs is unacceptable in the aviation industry. The
F‘AA’s primary duty, pursuant to statutory mandate,
is to consider the adverse safety consequences surround-
ing the issue of drug use by sensitive safety- and
security-related aviation personnel. On this basis, the
FAA has determined that employers should not be obli-
gated to offer an opportunity for rehabilitation, or to
provide job security to employees who fail a drug test
or who use drugs on the job. The FAA understands that
broad rehabilitation opportunities and job security for
employees, without regard to the manner of detection of
drug use, may help those employees who are unable to
help themselves. But, the FAA believes that it is incon-
78a
sistent with the agency’s safety responsibilities to pro-
mote the message that drug use in the aviation industry
will be tolerated until an individual’s drug use is de
tected through testing. The FAA believes that it is in-
appropriate to place the agency and an employer in the
anomalous position of allowing any employee who uses
illegal drugs to work in a sensitive safety- or security-
related position and whose drug use may adversely affect
aviation safety. Rather, the FAA believes that it is ap-
priate and consistent with its statutory safety mandate
to prohibit an employee who fails a drug test, who re-
fuses to submit to a drug test, or who uses drugs on the
job from actin gin a sensitive safety- or security-related
position. The FAA is convinced that the comprehensive
testing program of sensitive safety- and security-related
employees, combined with an employee assistance pro-
gram to educate and train all personnel, is consistent
with the statutory duty to promote aviation safety and
will reduce any drug use in the aviation community.
The FAA also carefully reviewed the third option pre-
sented in the NPRM that would provide an opportunity
for rehabilitation and job security to an employee who
admitted his or her drug use and who volunteered for
rehabilitation before being detected through drug testing.
However, in the FAA’s opinion and as noted by the com-
menters, there are several issues related to employee
rehabilitation and retention o~ reemployment benefits
that must be considered in < --lopment of the final rule.
For example, the term “rehabilitation” generally
means the period of time during which an employee is
receiving treatment or counseling for a drug problem.
The length of any rehabilitation period is dependent on
several factors such as the availability and enrollment
period of rehabilitation services, the length and extent
of treatment for the level of use and the type of drug
used, collection and analysis of tests given during re-
habilitation, and the review process that may lead to a
79a
recommendation to return to duty in a sensitive safety-
or security-related position. The term “rehabilitated”
generally means that an employee is determined to be
drug free and, based on the employee’s progress and
prognosis during rehabilitation, the employee may return
to work. The fact that an employee has returned to
work does not mean that the employee is exempt from
follow-up or aftercare treatment and counseling.
The FAA is aware of the wide variety of rehabilita-
tion programs that vary both in the length of treatment
and type of treatment depending on the substance used
and the availability of rehabilitation and treatment serv-
ices. One standard rehabilitation and treatment pro-
gram, generally necessary for those individuals who re-
quire intensive inpatient care followed by outpatient care
and counseling sessions, specifies 28 days of inpatient
care. Other programs may involve shorter periods of
time for inpatient care, may involve outpatient treatment
only, or may involve a combination of inpatient and out-
patient care of varied duration. For example, some
treatment programs may require three to four sessions,
given on two or three nights a week, over a six to eight
week period and followed by less frequent meetings or
counseling sessions. Other treatment programs might in-
volve individual or group counseling sessions on a weekly
basis, over a period of one year or more. An additional
factor that affects the length or treatment or rehabilita-
tion is the availability of private or community services
in a particular area.
The FAA reviewed these variables to determine if a
timeframe for voluntary rehabilitation and job security
could be developed and included in the final rule. The
FAA carefully considered the comments from many avia-
tion businesses that oppose any regulatory requirement
to offer rehabilitation and to retain or rehire any em-
ployee who admits to illegal drug use. The commenters
base their objections on several factors including elimina-
80a
tion of an employer’s discretion to terminate an em-
ployee; undue complication of operations due to poten-
tial extended absences of employees enrolled in rehabili-
tation; and negation of an employer’s ability to tailor
rehabilitation opportunities and job security to a partic-
ular employee population. The most strenuous objections
are based on the substantial and unwarranted burdens,
both administrative and financial, associated with reha-
bilitation and job security for employees. Based on fi-
nancial information submitted by the commenters, it ap-
pears that expenses of rehabilitation and job security
opportunities as proposed would seriously affect large
aviation entities and would probably overwhelm small
companies.
After review of the considerable variables in treat-
ment and the extensive arguments presented by the com-
menters, the FAA concluded that a reasonable accommo-
dation of burdens on employers who may not be able to
absorb employee absences and realistic opportunities for
employee rehabilitation can not be imposed in the ab-
stract. Thus, the FAA does not agree with the com-
menters who state that the FAA should specify an op-
portunity for rehabilitation and the amount of time dur-
ing which an employer is required to provide job security
for an employee enrolled in rehabilitation.
Many employers in the aviation industry currently of-
fer rehabilitation opportunities and job security benefits
to employees. The FAA anticipates that those employ-
ers will continue to offer these opportunities and bene-
fits to employees and that other employers may elect to
include these components in any negotiated employee
benefit package. Because many aviation entities have re-
solved the relative administrative, personnel, operational,
and financial issues that surround employee rehabilita-
tion and job security requirements, the FAA believes
that the aviation industry is able to design appropriate
programs and services for its employees. The FAA be-
ee ee ea ae ae ere
Ron cid Didi sion ar pled a
8la
lieves that, in light of the variables and burdens ad-
dressed above, issues regarding an adequate amount of
time for rehabilitation, an appropriate amount of time
to receive a recommendation to return to duty in a sen-
sitive safety-or security-related position, and job security
matters, are best addressed in the specific employment
context.
Thus, an employer is not required to offer an oppor-
tunity for rehabilitation, to provide job security, or to
provide the resources for rehabilitation to any employee.
At the same time, employers may offer these opportuni-
ties and benefits to employees; the FAA urges employers
to consider the experience of employers who have devel-
oped rehabilitation programs.
The final rule does not prohibit an employer from re-
assigning an employee to a position that does not involve
the performance of sensitive safety- or security-related
duties. The final rule also does not dictate whether an
employee is required or permitted to use vacation time,
sick leave, or leave without pay in order to accommodate
the employee’s time away from his or her sensitive
safety- or security-related position. The FAA believes
that issues such as termination, reassignment, hiring of
temporary employees to fill a position, or policies regard-
ing an employee’s absence from a position, are issues
that are appropriately the subject of employer and em-
ployee negotiation or collective bargaining.
The NPRM did not propose to
This text is long and has been trimmed here. Open the source document for the complete record.
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.